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“The most beautiful experience we can have is the mysterious - the fundamental emotion 
which stands at the cradle of true art and true science.”  
 -Albert Einstein- 
 
 
“In scientific research neither the level of intelligence nor the capacity to conduct and the 
undertaken task are essential elements for the success. Both of them are more accounted for 
total dedication and for closing the eyes in front of the difficulties: in this way we can face 
those problems that others, more critical and acute, won’t face.” 
-Rita Levi Montalcini- 
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Age related mitochondrial decline has been reported in different organisms, and is 
accompanied by a reduction in mitochondrial respiratory activity, morphological 
alterations and progressive accumulation of mutations. Besides their role in ATP 
production, mitochondria take also part in the transduction of intracellular signals, in 
cell death and they are the main sites of production of oxygen reactive species (ROS), 
detrimental molecules that promote mitochondrial dysfunction and ageing.  
Recent evidence showed that ROS may act also as signaling molecules to regulate cell 
growth, immune response and lifespan extension and that mutations that reduce the 
activity of the nutritional signaling pathways TOR/SCH9 and RAS/PKA induce an 
increase in chronological lifespan (CLS) extension in different model organisms, 
redirecting cells towards a respiratory metabolism and promoting stress resistance.  
In order to assess the relationship between mitochondrial function and ageing we 
investigated whether the increased CLS of some well-known longevity mutants 
correlated with an increase in mitochondrial DNA stability. Among the different 
longevity mutations analyzed only two, sch9∆ and rei1∆, accumulate large-scale 
rearrangements on mtDNA at lower rate compared to the parental strain, while there is 
no difference in the accumulation of point-mutations. 
This result suggests that large-scale rearrangements on mtDNA have a primary role in 
the senescence process as mtDNA integrity is strictly important to maintain proper 
mitochondrial function and respiratory activity, a key determinant of lifespan extension. 
Moreover, the evidence that only two of the eight longevity mutations analyzed were 
able to increase mitochondrial DNA stability indicates that maintenance of mtDNA is 
only one of the actors involved in the regulation of the ageing process and that 
different mechanisms cooperate to regulate lifespan extension in yeast.  
Sch9∆ and rei1∆ longevity mutants show high rate of respiratory activity accompanied 
by no significant difference in mtDNA amount, suggesting that the increased 
respiratory rate is imputable to an increased OXPHOS complexes content. We have 
been able to identify two different mechanisms through which the two longevity 
mutants promote lifespan extension and mtDNA stability. Deletion of SCH9 leads to an 
increase of ROS production early during growth to promote an adaptive signal that 
stimulates lifespan extension and reduces oxidative damage in stationary cells, 
activating a stress response program mediated by Sod2p overexpression. REI1 belongs 
to the RiBi genes regulon and the increase in mitochondrial DNA stability upon REI1 
deletion was observed also in other genes involved in ribosome biogenesis. In addition, 
we showed that reduced mtDNA rearrangements and increased respiratory activity in 
rei1∆ longevity mutant depend on a mechanism completely different from the adaptive 
response observed in sch9∆ mutant, and appear to rely on a direct stabilization of 
mitochondrial DNA through overexpression of nucleoid components.  
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1.1. MITOCHONDRIA 
 
1.1.1. Mitochondrial structure and function 
Mitochondria are eukaryotic organelles originated, according to the endosymbiotic 
theory, through an ancestral symbiotic event (Margulis 1975; Margulis & Bermudes 
1985). They are commonly referred as  the “powerhouse” of the cell because of their 
main function which is to generate chemical energy in the form of adenosine 
triphosphate (ATP), through the processes of aerobic respiration and oxidative 
phosphorylation.  
In addition to their essential role in cellular energy supply, other several cellular 
processes occur in mitochondria such as heme and Fe/S clusters biogenesis, calcium 
homeostasis, pyruvate oxidation, the reactions of the tri-carboxylic acid cycle (TCA, 
Krebs cycle) and of metabolism of fatty acids, amino acids, cholesterol, steroids and 
nucleotides (Scheffler, 2008). Mitochondria take also part in the transduction of 
intracellular signals, in cell death, aging and they are the main sites of production of 
oxygen reactive species (ROS).  
The multitude of different mitochondrial functions reflects into the complexity of their 
structure. Mitochondria are elliptic organelles of variable size, generally between 3-4 
µm of length and 0.2-1 µm of diameter. Mitochondria are surrounded by a double 
membrane, the outer mitochondrial membrane (OMM) and the inner mitochondrial 
membrane (IMM), which create different compartments that carry out specialized 
functions (McBride et al. 2006).  
The OMM is a lipid rich layer and contains large number of integrated proteins (porins),  
which form channels that allow molecules smaller than 10 kDa to freely diffuse across 
the membrane in both directions. The transfer of larger nuclear encoded proteins is 
mediated by the recognition of import sequences at their N-terminus by a 
multisubunit protein called translocase of the outer membrane (TOM), which actively 
moves them across the membrane (J M Herrmann & W Neupert 2000).  
The IMM shows the highest ratio protein-phospholipid among the biological 
membranes and is enriched with the unusual phospholipid, cardiolipin (J M Herrmann, 
2011). This particular composition makes the IMM highly impermeable but the 
presence of specific carriers (among them is worth to mention the translocase of the 
inner mitochondrial membrane, TIM) allows the exchange of metabolites between 
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mitochondria and cytoplasm and the formation of a ionic gradient  (Guérin, 1991). The 
space between the OMM and the IMM is called inter-membrane space, while the space 
enclosed by the IMM is the mitochondrial matrix. 
  
Figure 1.1.  A) Electron microscopy image of a mitochondrion;  B) Graphic representation of 
mitochondria.  
The IMM is folded and compartmentalized into numerous invaginations called cristae 
where all the respiratory complexes are localized; the organization in these structures 
expand the surface area of the membrane enhancing its ability to produce ATP.  
The number and morphology of cristae reflect the response of mitochondria to the 
energy demand of the cell. Highly folded lamellar cristae, with a large surface area, are 
typically found in tissues with high energy demand such as muscle, brain and hearth 
(Scheffler, 2008).  
The number of mitochondria varies depending on the cell type we consider and the 
metabolic state of the cell; their distribution inside the cell depends on the site where 
mitochondria output is required (Bereiter-Hahn & Vöth 1994; Warren & Wickner 1996).  
Inside the cell the mitochondria are not dispersed as isolated organelles but they are 
organized in a highly branched, reticulated structure (Hoffmann & Avers 1973; Stevens 
1981).  
Mitochondria have to be considered dynamic organelles whose morphology constantly 
change through the coordination of fusion and fission events (Nunnari et al. 1997; 
Dimmer et al. 2002; McBride et al. 2006). These processes are believed to provide a 
  
A) B) 
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mitochondrial quality control system and enable an effective adaptation of the 
mitochondrial compartment to the metabolic needs of the cell (Westermann, 2010).  
A peculiar aspect that characterizes mitochondria is the fact that they retain their own 
genome (mtDNA) and machinery for protein synthesis.  
Damage and subsequent dysfunction in mitochondria can lead to various human 
diseases, due to their influence in cell metabolism. Mitochondrial disorders include a 
wide range of clinical phenotypes and often present themselves as neurological 
disorders, but can also manifest as myopathy, diabetes, or multiple endocrinopathy (D 
C Wallace 2001; Massimo Zeviani & Di Donato 2004). 
 
 
1.1.2. Mitochondrial DNA 
Mitochondrial DNA is present into mitochondria in multiple copies and their number 
vary depending on growth conditions, environmental factors and in metazoans on the 
tissues we consider.  
The majority of studied organisms present a circular molecule of mitochondrial DNA 
(mtDNA), whose extension varies considerably between metazoan, plants and fungi 
(Table 1.1). The different size of mtDNA does not necessarily correlates with the 
number of genes retained by these genomes. 
 
Table 1.1. Mitochondrial DNA size in different organisms and number of genes encoded by the organelle 
genome (Lang et al., 1999). 
Class Genome size (Kb) Proteins coding genes RNA coding genes 
Fungi 19-100 8-14 10-28 
Protists 6-100 3-62 2-29 
Plants 186-366 27-34 21-30 
Animals 16-17 13 4-24 
 
In many organisms (e.g. the ciliate Paramecium Aurelia, the algae Chlamydomonas 
reinhadtii and the fungi Candida, Pichia) mtDNA is found as a linearly organized DNA (J 
Nosek et al. 1998). In some plants and fungi, including Saccharomyces cerevisiae, in 
vivo the linear form of mtDNA is the prevalent one and is organized in linear 
multiconcatamers (Bendich 1996; J Nosek et al. 1998; Jozef Nosek & Lubomír Tomáska 
2003). 
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Human mtDNA is a double-stranded circular molecule of 16.5 Kb (fig.1.2) whose 
complete sequence has been characterized, and usually are present 100-10,000 copies 
of mtDNA per cell (S. Anderson et al. 1981). The nucleotide content of the two strands 
of mtDNA is different: the guanine rich strand is referred as the heavy strand and the 
cytosine rich strand is referred as the light strand.  
 
 
Figure 1.2. Maps of yeast and human mtDNAs. Each map is shown as two concentric circles 
corresponding to the two strands of the DNA helix.  Green : exons and uninterrupted genes, red : tRNA 
genes, yellow: URFs (unassigned reading frames).  tRNA genes are shown by their amino 
acid abbreviations; ND genes code for subunits of NADH dehydrogenase. Note that the human map is not 
drawn to the same scale as the yeast map. From: Inheritance of Organelle Genes,  1999, W. H. Freeman 
and Company. 
 
Most of the original mitochondrial genes have been transferred to the nuclear genome, 
which now harbors the vast majority of the genes encoding for the ca. ~1500 proteins 
localized to mitochondria. Among the 37 genes contained in human mtDNA, 28 genes 
are encoded by the heavy strand and 9 by the light strand: 13 genes encodes for 
proteins of respiratory complexes, 22 encodes for mitochondrial tRNAs and 2 for two 
mitochondrial rRNAs (12S and 18S) essential for mitochondrial translation. The genetic 
information in human mtDNA is highly compacted with genes separated by few 
nucleotides or overlapping and no introns or UTR regions (Scheffler, 2008).  
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Yeast mtDNA is organized both in linear and circular molecules and has a size ranging 
from 68 Kb (short strains) to 86 Kb (long strains), whose difference is imputable to 
non-coding and intronic sequences. In particular, the genome of Saccharomyces 
cerevisiae is 86 Kb and the complete sequence was first published in 1998 (F Foury et 
al. 1998).  
Unlike human mtDNA, in yeast there are few introns interspersed between coding 
sequences, non-coding regions and the degree of compaction is lower. The yeast 
mitochondrial genome contains genes for cytochrome c oxidase subunits (cox1, cox2, 
cox3), ATP synthase subunits (atp6, atp8, atp9), cytochrome b in complex III, a single 
ribosomal protein Var1p, and several intron related ORFs.  
The introns contained in 21S rRNA, COX1 and COB are translated independently or in 
frame with their upstream exons to produce maturases, reverse transcriptase and 
endonucleases (F Foury et al. 1998). However, it is worth of noting that unlike human 
mtDNA, in yeast there are no genes for complex I subunits that consists of only one 
protein encoded by nuclear genome.  
In addition mtDNA encodes for 21S and 15S ribosomal RNAs, 24 tRNAs that recognize 
all the codons, the 9S RNA component of RNAase P and seven to eight replication 
origin-like regions.  
 
 
1.1.3. Mitochondrial DNA organization                
Unlike nuclear DNA, mtDNA is not associate with histones and organized in 
nucleosomes. Several proteins interact with mitochondrial DNA, packing it in a 
structure called nucleoid which was found to be associate with the inner mitochondrial 
membrane (Miyakawa et al. 1987; X. J. Chen & Ronald A Butow 2005; Malka et al. 
2006; Kucej & Ronald a Butow 2007).  
Haploid cells of the yeast Saccharomyces cerevisiae contain 40 nucleoids per cell, each 
one holding more than one copy of mtDNA and representing an inheritable unit 
(Williamson & Fennell 1979; H T Jacobs et al. 2000).  
Nucleoid is a dynamic structure whose organization change according to metabolic 
cues and whose proper distribution requires frequent event of fission and fusion 
(fig.1.3) (MacAlpine et al. 2000; Kucej et al. 2008).  
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Figure 1.3.  a) In the presence of glucose, mtDNA is tightly packaged by the protein Abf2, limiting mtDNA 
transactions.  b) When cells are shifted to respiratory conditions, ACO1 expression is increased.  c) 
Similarly, in conditions of amino-acid starvation, the expression of ILV5 is activated by the general 
amino-acid control pathway and Ilv5p accumulates in mitochondrial nucleoids.  The increased levels of 
Aco1p and Ilv5p substitute for Abf2p packaging mtDNA into a metabolically favorable conformation 
and/or protect mtDNA in the remodeled conformation (from Chen & Butow, 2005).     
 
The packing of mtDNA requires both proteins directly involved in mitochondrial DNA 
maintenance and proteins with apparently unrelated functions (X. J. Chen et al. 2005). 
In the yeast Saccharomyces cerevisiae have been identified 22 proteins involved in 
nucleoid formation, and they can be grouped in two classes: proteins associated to 
mtDNA and involved in DNA replication, transcription, repair, recombination, and 
proteins involved in cytoskeletal organization, import and mitochondrial biogenesis, 
metabolism or proteins responsible of protein quality control.  
Abf2 is a protein that belongs to the first functional category and is able to bend 
mtDNA, inducing supercoiling in the presence of a topoisomerase. In addition to its 
role in mtDNA packing, Abf2p has been shown to be involved in replication and in the 
recruitment of other mitochondrial proteins to nucleoids (Newman et al. 1996; 
Zelenaya-Troitskaya et al. 1998; Friddle et al. 2004). Deletion of ABF2 leads to a strong 
mtDNA instability. Other proteins have been shown to bend mtDNA such as Rim1p 
(protein that bind ssDNA), Mgm101p (enzyme involved in mtDNA repair) and Sls1p 
(involved in mtDNA transcription).  
In the other functional class we find many bi-functional proteins: mtHsp60, mtHsp70, 
mtHsp10 are proteins involved both in mitochondrial protein import and nucleoid 
organization; deletion of HSP60 impairs nucleoids segregation with subsequent loss of 
mtDNA in daughter cells. Many metabolic enzymes involved in  Krebs cycle, glycolysis 
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or amino acids metabolism are actually mtDNA stabilizing proteins (B Kaufman et al. 
2000).  
Among these there is aconitase, whose function in nucleoid is independent of his 
enzymatic activity (X. J. Chen et al. 2005; X. J. Chen et al. 2007), and Ilv5 which is a 
protein involved in the biosynthesis of isoleucine, leucine and valine and required for 
mtDNA stability. Expression of the ILV5 gene is regulated by the general amino acids 
control pathway and is a target for the transcription activator Gcn4 (MacAlpine et al. 
2000).  
Ilv5p rescues the high mtDNA instability due to ABF2 deletion and seems to be 
required to maintain the stoichiometric ratio between nucleoids and mtDNA copy 
number. Proteins having a dual function both as metabolic enzymes and stabilizers of 
mtDNA are interesting because they provide a mechanism for coupling mtDNA 
maintenance to metabolism regulation.  
One possibility is that bi-functional proteins have evolved as sensors for metabolic 
changes that can be transmitted by nucleoids to regulate mtDNA maintenance. For 
example proteins such as aconitase and Ilv5 are crucial for carbohydrate and nitrogen 
metabolism respectively and, at the same time, for mtDNA stability. Their presence in 
nucleoids suggests a mechanism for the metabolic control of mtDNA and nucleoid 
activity; in this way metabolic signals maybe translated altering nucleoids structure to 
control mtDNA maintenance (Kucej & Ronald a Butow 2007).  
Mitochondrial DNA accumulates mutations at a significantly higher rate compared to 
nuclear genome for several reasons: the lack of protective histones, the high 
replication rate increasing the likelihood of errors and the proximity to inner 
mitochondrial membrane and electron transport chain, which is the major source of 
oxygen reactive species. For all that reasons the nucleoid has a pivotal role in packing 
mtDNA to prevent oxidative damage and genome instability.  
 
 
1.2. FUNCTIONS 
 
As pointed out before mitochondria are involved in a large number of  processes, 
although their main role is to generate the majority of ATP for cellular functions, via 
the oxidative phosphorylation. The most important energy sources for the cell are 
represented by sugars, fatty acids and proteins whose oxidative degradation take place 
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in cytosol. In aerobic organisms these substrates are oxidized to CO2 and H2O, coupled 
to ATP production through a series of reactions known as cellular respiration.  
 
 
Figure 1.4.  Some metabolic pathways that take place inside of mitochondria for energy supply (from 
Turner and Heilbronn, 2008). 
 
 
1.2.1. Sugars and fatty acids oxidation 
Different catabolic pathways are involved in the oxidation of sugars and fatty acids: 
cytosolic glycolysis is a central pathway that allows the conversion of glucose in two 
molecules of pyruvate, 2 ATP and 2 NADH for each molecule of glucose processed. In 
aerobiosis, the glycolysis represents only the first step of glucose degradation: each 
pyruvate molecule produced is actively transported inside mitochondria, where it 
undergoes further oxidation by pyruvate dehydrogenase to acetyl-CoA that enters in 
Krebs cycle, with a net gain in ATP production (Perham 2000).  
In anaerobiosis, pyruvate is converted to lactate or, in yeast, to ethanol by lactic or 
alcoholic fermentation. Fatty acids are highly negatively charged molecules and they 
need to be activated and converted in acyl-CoA in cytosol. Once activated, fatty acids 
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are imported in mitochondria, through an acetyl-carnitine carrier and oxidized to 
acetyl-CoA by a four steps reaction commonly known as ϐ-oxidation.  
In animals cells the degradation of very long fatty acids is carried out by peroxisomes, 
where fatty acids are shortened to be easily accepted by the mitochondrial system 
(Scheffler 2008). In yeast strains ß-oxidation is restricted to peroxisomes, without 
coupling the process to ATP synthesis; the high potential electrons are transferred to 
O2 yielding H2O2. The enzyme catalase converts hydrogen peroxide into water and 
oxygen. The acetyl-CoA units generated in peroxisomes are then transferred into 
mitochondria by the carnitine shuttle.  
Acetyl-CoA is a key component of metabolism and represents the conversion point of 
different degradation pathways. The acetyl-CoA units obtained both from glycolysis, 
fatty acids oxidation and from catabolism of some amino acids (glutamate, lysine) 
enter in the Krebs cycle and are oxidized to CO2. 
 
 
1.2.2. Krebs cycle 
Krebs cycle, also known as tricarboxylic acid cycle (TCA), consists of eight reactions 
used by all aerobic organisms and occupies a central position in metabolism. The Krebs 
cycle is an amphibolic pathway: many catabolic processes converge on it and many 
intermediates produced by the cycle are precursors used in anabolic reactions (e.g. α-
ketoglutarate is precursor for amino acids and nucleotides, succinil-CoA is used for 
heme biosynthesis) (Scheffler, 2008).  
In eukaryotic cells the TCA cycle occurs in mitochondrial matrix where acetyl-CoA is 
oxidized to CO2 with the reduction of NAD
+, FAD+ and ubiquinone. Stoichiometrically 1 
molecule of acetyl-CoA is converted in 2 CO2 with production of 3 NADH, 1 FADH2  and 
one high energy GTP molecule. All the enzymes of the citric acid cycle are soluble 
enzymes in mitochondrial matrix, with the only exception of succinate dehydrogenase. 
This enzyme is the only one in Krebs cycle directly linked to the electron transfer chain 
(complex II), and represents a connection between TCA cycle and oxidative 
phosphorylation.  
The succinate dehydrogenase consists of four subunits: in yeast Sdh1p and Sdh2p 
form the catalytic core, which faces mitochondrial matrix, while Sdh3p and Sdh4p are 
two integral membrane proteins that anchors the complex to the inner mitochondrial 
membrane (Lemire & Oyedotun 2002). The cycle is useful to increase the cells ATP 
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production potential by generating reduced carriers whose electrons are passed 
through the electron transport chain. 
 
 
Figure 1.5.  Schematic representation of all the reactions and intermediates involved in Krebs cycle. 
 
 
1.2.3. Oxidative phosphorylation 
Catabolic pathways involved in the oxidation of carbohydrates, proteins and fatty acids 
flow together into the final step of cellular respiration, wherein the energy released by 
oxidation processes is used for ATP synthesis. During oxidative phosphorylation the 
electrons derived from NADH or FADH2 are passed through an electron transport chain 
(ETC) consisting of carriers of increasing reduction potential, ultimately being 
deposited on molecular oxygen with formation of water. The free energy derived from 
the electron flow is used to actively pump out protons from the mitochondrial matrix to 
the intermembrane space (D C Wallace et al. 1988; Salvatore DiMauro & Eric A Schon 
2003).  
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This generates an electrochemical potential across the membrane, which is used to 
drive ATP synthesis, by allowing protons to flow back across the IMM. NADH electrons 
are sufficient to produce three ATP molecules, while two ATP molecules are obtained 
from FADH2 electrons.  
 
 
 
Figure 1.6. Mitochondrial electron transport chain complexes and soluble carriers. The image is taken 
from KEGG pathway.  
 
The flow of electrons involves both soluble and protein-bound transfer molecules, that 
are cyclically reduced and oxidized. In ETC tree groups of transporters are involved: 
- Coenzyme Q or ubiquinone: small and highly hydrophobic molecule that freely 
diffuse in the inner mitochondrial membrane and may act as a shuttle between 
other membrane-bound transporters. Coenzyme Q carries both electrons and 
protons and exists in three redox states: fully oxidized (ubiquinone), 
semiquinone (ubisemiquinone), and fully reduced (ubiquinol). 
- Cytochromes: mitochondrial proteins that contain heme groups, bound either 
covalently or not. They are involved only in the electrons flow, transferring 
them by the reduction and oxidation of a metal ion (usually an iron atom), that 
the protein holds within the heme group. Three classes of cytochromes exist in 
mitochondria and they are distinguishable by their visible adsorption maxima; in 
a-type cytochromes the maximum adsorption peak is around 602 nm, in b-type 
cytochromes  at around 560 nm and in c-type cytochromes at about 550 nm. In 
cytochromes a and b the heme group is strongly but not covalently bounded to 
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the protein, while in c-type cytochromes is covalently associated to cysteine 
residues of the protein. 
- Iron-sulfur clusters: the iron atom is bound to inorganic sulfur atoms and/or to 
sulfur atoms of cysteine residues in the protein. The clusters can be really 
simple, with one iron atom coordinated by four sulfur atoms, or more complex 
with two or four iron atoms. The Fe-S cluster proteins are involved in redox 
reactions in which only one electron at time is transferred, with change of the  
iron redox state.  
 
Four membrane-bound complexes have been identified in mitochondria, and they 
consist of multiple peptide intermembrane structures anchored to the IMM. Each 
complex is structurally in tight contact with the other ones, and functionally connected 
via mobile carriers (cytochrome c, ubiquinone). Complex I or NADH ubiquinone 
oxidoreductase catalyzes the following reaction: 
                                 
NADH+Q+5Hi
+  =>  NAD++QH2+4H0
+ 
 
with the transfer of four protons from the matrix to the intermembrane space. In 
mammalians mitochondria complex I is made of 45 subunits (>900 KDa), seven of 
which are encoded by mtDNA (ND1, ND2, ND3, ND4L, ND5, ND6). Complex I is tightly 
associated to the prosthetic group flavin mononucleotide (FMN), and contains different 
iron-sulfur clusters that transfer electrons from reduced FMN to coenzyme Q. High 
resolution electron microscopy showed that the complex has an L shape, with one arm 
dispersed into IMM and the other one facing mitochondrial matrix (Mckenzie & Ryan 
2010).  
Unlike mammals, common fission and budding yeasts lacks of complex I and use 
instead a completely different enzyme for electron transfer from NADH to ubiquinone, 
which does not pump protons out of the matrix.  
Complex II, also known as succinate dehydrogenase, is the only enzyme that directly 
links Krebs cycle to ETC coupling the oxidation of succinate to fumarate with the 
reduction of coenzyme Q. The complex consists of four subunits: two integral 
membrane proteins anchors the complex to inner mitochondrial membrane while the 
two largest peptide organize the enzyme catalytic core. The latter transfers the 
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electrons from succinate to a flavin adenine dinucleotide cofactor (FAD), and then to 
three Fe-S clusters with the subsequent reduction of coenzyme Q.  
Complex II does not pump electrons from matrix to IMS, because the amount of free 
energy originated from electron transfer from FADH2 to CoQ is too low. Actually, this is 
the reason why the electrons flowed in ETC by FADH2  produce only 2 ATP molecules 
instead of the three obtained from complex I NADH oxidation, which involves complex 
I.  
The ubiquinol-cytochrome c oxireductase or simply cytochrome bc1 is the third complex 
in ETC (complex III). This complex is a multi-subunits protein, whose components are 
quite similar in different species such as yeasts, animals and plants.  
Only one peptide of the complex is encoded by mtDNA (cytochrome b), while the 
others (8 in yeast and 10 in mammals) are encoded by nuclear DNA and imported for 
assembly in the inner mitochondrial membrane. Complex III catalyzes the oxidation of 
coenzyme Q (QH2), by transferring the electrons to cytochrome c and pumping two 
protons in the intermembrane space.  
Functionally, the most important subunits of cytochrome bc1 are the cytochromes b 
(b562 and b566) and c1 and the Rieske iron-sulfur proteins. These are the only 
proteins participating in the reaction and actually in bacteria, the correspondent 
complex involved in electron transfer, includes only these three proteins. Anyway yeast 
mutants for each subunit of complex III have been shown to be respiratory deficient, 
indicating that even the subunits lacking the prosthetic groups have a relevant role, 
perhaps in the assembly and stabilization of the complex (Scheffler 2008).  
Electrons flow from the reduced Q10 to cytochrome b and then they shuttle through 
the Fe-S centers to cytochrome c. 
 
QH2 + Cyt c
3+ + 2Hi
+   =>   Q + 2 Cyt c2+ + 4Ho
+ 
 
Unlike other cytochromes, cytochrome c is not associated to additional proteins but is 
loosely bound to the IMM and is able to freely diffuse along the mitochondrial 
membrane. The reaction mechanism of complex III is  known as the ubiquinone cycle: 
two ubiquinone reaction centers are present in complex III and involved in the cycle. 
The Qn or quinone reduction center is located in the matrix side of the IMM, while the 
Qp center is located close to the outer face of the IMM. Ubiquinol (QH2) is therefore 
oxidized by transfer of one electron to the Rieske protein and one to cytochrome b; 
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once reduced by the electron coming from Qp center, the Rieske protein shuttles the 
electron to cytochrome c1 which in turns completes the reaction through the reduction 
of the soluble cytochrome c.  
The other electron is transferred from one cytochrome b moiety to the second one, 
and then shuffled to the ubiquinone bound at the Qn site. The next step is the reduction 
of ubiquinone to a semiquinone radical. A second Q cycle is necessary to complete the 
reduction of semiquinone to ubiquinol,  which re-enters in the cycle, using the electron 
of one cytochrome b reduced by a second ubiquinol cofactor which is released as 
ubiquinone.  
Once the cycle is completed four protons are released in the intermembrane space and 
two protons are taken up from the matrix, with a net transfer of two protons and the 
reduction of two molecules of cytochrome c.  
The reduced cytochrome c is then reoxidized by complex IV (cytochrome c oxidase), 
which catalyzes the electron transfer from soluble cytochrome c to the final acceptor 
molecular oxygen, with production of two molecules of H2O. This process involves two 
steps: two electrons are transferred on the IMS side, while four protons are taken up 
from the matrix side, resulting in the transfer of four positive charges across the 
membrane. In addition, an average of one proton is pumped through the enzyme for 
each electron transferred to oxygen (Brändén et al. 2006).  
In mammals the complex consists of 13 subunits, while in yeast there are only 9 
subunits. However in all organisms the three biggest subunits are encoded by 
mitochondrial DNA and synthesized in the matrix. The complex is a large integral 
membrane protein which includes two cytochromes (a and a3 ) and copper centers 
involved in the electron transfer. The last non respiratory complex involved in oxidative 
phosphorylation is ATP synthase (F1-F0 ATPase) or complex V.  
ATP synthase consists of two regions: the F0 portion is embedded in the inner 
membrane and organizes the channel that translocate protons back in the matrix while 
the F1 unit faces mitochondrial matrix, whose rotary motion is coupled to ATP 
production 
During ETC, the efflux of protons from mitochondrial matrix creates an electrochemical 
gradient across IMM which is used by ATP synthase to generate chemical energy in the 
form of ATP, starting from ADP and inorganic phosphate. . 
Once produced, ATP is exported in cytosol by an ATP/ADP carrier that at the same 
time imports ADP inside the matrix to be recycled. ATP synthase components are 
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encoded both by mitochondrial and nuclear genes; in yeast the nuclear genes appear 
to be constitutively expressed, regardless of the carbon source in contrast to nuclear 
genes for ETC (Ackerman & Alexander Tzagoloff 2005).  
Along ETC single electrons may escape prematurely, mainly from complex I and III, 
and react with oxygen leading to the formation of superoxide. This highly reactive ions 
can subsequently be converted into hydrogen peroxide and hydroxyl radicals, which 
are deleterious molecules commonly referred as reactive oxygen species (ROS). High 
levels of ROS are injurious and induce oxidative stress damaging proteins, lipids and 
mitochondrial DNA, while at lower concentrations they may act as a beneficial 
regulatory signal (Ristow & Schmeisser 2011).  
In healthy cells the superoxide ions are transformed by the protein superoxide 
dismutase, which will be discussed later.  
 
 
1.2.4. OXPHOS impairment 
A wide range of pathologies are associated with an impairment of mitochondrial 
function, whose primary consequence is the accumulation of metabolic intermediates, 
increased production of ROS and the decrease in ATP production. In general all the 
clinical phenotypes associated with biochemical and genetic defects affecting oxidative 
phosphorylation are referred as mitochondrial disorders (Massimo Zeviani & Di Donato 
2004).  
Mitochondrial disorders may arise as the result of mutations in both mitochondrial DNA 
or nuclear genes that code for mitochondrial components. For instance  in S. cerevisiae 
nuclear genome encodes for at least 500 proteins that localize in mitochondrion where 
they are involved in a wide range of functions (Lipinski et al. 2010).  
It is worthy of note that mitochondrial biogenesis depends on the cooperation between 
nuclear and mitochondrial genomes. Only a few polypeptides of respiratory complexes 
are encoded by mtDNA, while the vast majority is encoded in the nucleus and imported 
into mitochondria.  
Moreover transcription of mtDNA is carried out by a dedicated RNA polymerase and its 
associated transcription factors, all of them encoded by nuclear DNA. Mitochondrial 
translation apparatus is different from the one used to express nuclear genes and 
encoded by both nuclear and mitochondrial genome (all the protein components are 
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encoded by the nucleus, whereas all the RNA components have a mitochondrial origin) 
(Bonawitz et al. 2007).  
Mitochondrial disorders may therefore originate not only from mutations in 
mitochondrial structural genes impairing oxidative phosphorylation, but also from 
mutations in both nuclear and mitochondrial DNA. The latter affects mitochondrial 
protein synthesis and hence the biogenesis of multiple complexes, mtDNA replication 
and transcription, repair, RNA processing, as well as defects in protein import 
(Scheffler 2008).  
Mitochondrial diseases are heterogeneous and a considerable clinical variability exists 
in affected patients. One factor responsible for this variability lies in the homoplasmic 
or heteroplasmic status of mitochondria. A large number of copies of mtDNA is present 
within an eukaryotic cell, usually identical among them in a healthy individual at birth; 
this condition is referred to as homoplasmy.  
By contrast, a mixture of wild-type and mutated mtDNA can be present, a condition 
known as heteroplasmy (Holt et al. 1988; Holt et al. 1990). The fraction of mutated 
mtDNA can range from barely detectable to high percentage, and therefore the 
expression of the defect can range from mild to very severe. Consequently the clinical 
phenotypes and their severity vary widely (Scheffler 2008).  
It has been shown that the vast majority of mtDNA mutations are recessive and that 
the proportion of mutant mtDNA must exceed a critical threshold level, before the cell 
exhibit a biochemical defect (M. P. King & G Attardi 1988). Furthermore, the threshold 
level of mutant mtDNA may vary among individuals even within the same family, and 
also among different tissues and organs (Patrick F Chinnery 2000).  
Mitochondrial disorders preferentially affect tissues whose function depend on aerobic 
metabolism such as brain, muscles, heart, peripheral nerves, renal and endocrine 
system, enhancing the clinical variability observed. They are usually progressive and 
frequently induce disability and premature death (Leonard & Schapira 2000; S DiMauro 
& E A Schon 2001).  
The major clinical manifestations are myopathies, neuropathies, encephalomyopathies, 
ataxia, diabetes mellitus, mental retardation and ophthalmologic defects (McKenzie et 
al. 2004). As described above, mitochondrial diseases may arise both from nuclear and 
mitochondrial DNA mutations. Mitochondrial DNA mutations include single base 
substitutions and rearrangement mutations (deletions or partial duplications).  
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Point mutations are maternally inherited and may be both homoplasmic or 
eteroplasmic. They can be distinguished in missense mutations affecting structural 
genes or mutations in genes encoding for mitochondrial rRNA and tRNA, which globally 
compromise mitochondrial protein synthesis (D C Wallace 1999).  
Among them it is worth to mention the A3243G mutation in the tRNALEU  gene which is 
responsible for mitochondrial encephalopathy with lactic acidosis and stroke-like 
episodes (MELAS) syndrome, and a set of mutations affecting complex I activity 
responsible for Leber’s hereditary optic neuropathy (LHON).  
Mitochondrial DNA rearrangements, deletions and duplications, are generally 
associated with severe progressive diseases, usually sporadic and lethal. 
Rearrangements frequently occur in correspondence of directly repeated sequences 
and there is reason to believe that are the result of a de novo mutational event, arising 
during oogenesis or early embryogenesis (Rötig 2010). 
Large-scale rearrangements are mainly associated with two clinical conditions that 
have in common various symptoms: the first is the Kearns-Sayre syndrome (KSS) 
characterized by progressive ophthalmoparesis, pigmentary retinopathy, mental 
retardation and increased probability of complete hearth block. The second is the 
Pearson syndrome which induces pancytopenia and alteration in pancreatic exocrine 
function in childhood, while in adulthood it induces the typically clinical features of KSS 
(Scheffler 2008).  
As pointed out before, mutations in nuclear genes may give rise to mitochondrial 
diseases by directly and indirectly compromising OXPHOS function and mitochondrial 
metabolism, or by destabilizing mtDNA (D C Wallace 1999).  
The most common nuclear encoded mitochondrial disease is the Leigh syndrome, 
which is associated with an impairment of complex IV activity due to severe mutations 
in the SURF1 as well as SCO1 and SCO2 genes, involved in the delivery of copper to 
the complex (Tiranti et al. 1998; Zhu et al. 1998; Tiranti et al. 1999; Papadopoulou et 
al. 1999). The characterization of patients with reduced cytochrome oxidase activity 
revealed that the defective nuclear genes were mainly involved in the complex 
assembly.  
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Figure 1.7. List of the mitochondrial (red) and nuclear (black) encoded genes whose mutation is 
associated with mitochondrial diseases in humans. Genes are grouped according to the predicted 
localization of the corresponding protein: mitochondrial matrix (107 genes), outer membrane (9 genes), 
inner membrane (81 genes) and intermembrane space (7 genes). In the figure are also reported genes 
coding for proteins of unknown localization (15 genes) and gene products that partially localize to 
mitochondria (22 genes).   
 
 
Other patients have been identified with a reduced activity of complex I due to 
mutations in NDUFS1, NDUFS4, NDUFS7, NDUSF8 genes, or with the impairment of 
complex II function because of mutations in SDHB, SDHC, SDHD genes that result in 
the formation of an unusual class of tumor known as paragangliamas (Astuti et al. 
2001; Chew 2001; Douwes Dekker et al. 2003; Procaccio & Douglas C Wallace 2004; 
Raimundo et al. 2011).  
Complex III-associated deficiencies are rather uncommon, but for example deletion of 
the nuclear gene UQCRB, encoding the human ubiquinone binding protein of complex 
III, has been reported in a consanguineous family.  
A large number of patients carrying mutations in nuclear genes involved in mtDNA 
maintenance and replication have been identified. Mitochondrial DNA deletions can be 
caused by mutations in enzymes of the replication machinery as mtDNA polymerase or 
the elicase TWINKLE, or by mutations in enzymes involved in the regulation of the 
mitochondrial nucleotide pool as the thymidine phosphorylase or the adenine 
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nucleotide translocator (ANT1) (Kaukonen et al. 2000; Nishino et al. 2001). Among 
others mitochondrial disorders those due to a quantitative reduction of mtDNA copy 
number are worth mentioning, and are  known as depletion syndromes.  
The mtDNA depletion syndrome was first described by Moraes and coworkers as a fatal 
rare disorder, which shows up in early childhood, and which has been identified in 
several families (Moraes et al. 1991). The disorder is associated with an autosomal 
recessive trait that causes a severe depletion of mitochondrial DNA in specific tissues, 
most frequently liver, brain, heart and muscles.  
A peculiar aspect is that no mutations in mitochondrial genes have been identified, 
otherwise the defect appears to reside on nuclear genes: the thymidine kinase 2 (TK2) 
and deoxyguanosine kinase (DGUOK) genes encode for proteins involved in a pathway 
responsible for the rescue of mitochondrial deoxyribonucleotides, the main source of 
precursors for mtDNA , while the POLG gene has a direct role in mtDNA replication. 
 
 
1.3. MITOCHONDRIA AND AGEING 
.    
Due to their central role in cellular metabolism, mitochondria are important 
determinants of lifespan and healthspan. Beyond mitochondrial disorders, impairment 
of mitochondrial function, by altering bioenergetics efficiency and decreasing stress 
resistance, has long been implicated in late-onset neurodegenerative disorders 
(Alzheimer’s disease, Parkinson’s disease, Hungtington’s disease and amyotrophic 
lateral sclerosis) and in the ageing process (Rourke et al. 2002). During the past two 
decades research has been focused on the understanding of molecular and genetic 
basis of ageing, and to which extent it correlates with mitochondrial dysfunction. 
 
  
1.3.1.    The mitochondrial theory of ageing 
Age related mitochondrial decline has been reported in different organisms and it is a 
proven evidence that ageing is accompanied by a decline in mitochondrial respiratory 
activity, accumulation of somatic mutations and morphological alterations including 
enlargement, matrix vacuolization and abnormal cristae (Shigenaga et al. 1994). 
Despite the clear evidences which show a tight relationship between mitochondrial 
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dysfunction, ageing and neurodegenerative pathologies, the mechanisms behind these 
processes still remains largely unknown.  
Undoubtedly mitochondrion is a key player in the ageing process, but the challenge is 
to clarify if the decline of mitochondrial functions is central to the process or just a 
strong contributor influencing the timing and the severity of the overall deterioration 
(Scheffler 2008). Among the multiple theories proposed to explain the ageing process 
the mitochondrial theory of ageing, proposed by Harman in 1972, is still the prevalent 
(Harman 1972).  
According to the theory, ageing results from a continuous process of accumulation of 
damages originated by reactive oxygen species (ROS), the byproducts of cellular 
respiration. Flowing along the ETC complexes, electrons can prematurely react with 
molecular oxygen leading to the formation of superoxide, hydrogen peroxide and 
hydroxyl radicals (Bonawitz & Shadel 2007).  
Mitochondria are the main site of ROS production, which in turn triggers out a vicious 
cycle: by inducing oxidative damage to mitochondrial macromolecules, including 
mtDNA, ROS lead to impaired OXPHOS function and even greater ROS production 
(Balaban et al. 2005).  
The major ROS production depends on complex I and complex III, and once produced 
the superoxide anion could be furthermore reduced to hydroxyl radical or react with 
nitric oxide to form a highly oxidizing peroxynitrite anion (Andreyev et al. 2005). 
Eukaryotic cells have evolved defense mechanisms based on proteins such as 
superoxide dismutase (cytosolic Sod1p or Cu/ZnSodp and mitochondrial Sod2p or 
MnSodp), catalase, glutathione reductase and peroxidases which convert the 
deleterious ROS into non-toxic molecules.  
In particular the manganese-dependent superoxide dismutase, localized in 
mitochondrial matrix, catalyzes the dismutation of superoxide into molecular oxygen 
and hydrogen peroxide. The latter is converted into water through enzymatic reactions 
catalyzed by catalase and glutathione peroxidase in the cytosol (Andreyev et al. 2005). 
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Figure 1.8. Molecular events related to normal and stress-induced senescence. ROS damage in part is 
rescued by scavenging systems. Once cellular components are damaged (red asterisks) they may be 
removed and replaced by newly synthesized proteins, if mtDNA is functional. If damage to mitochondria 
is too severe a retrograde response signals to the nucleus and induces the expression of additional genes 
that can rescue lost functions. Damage, however, also lead to the induction of apoptosis (from EMBO 
reports 3, 12, 1127–1132, 2002). 
 
 
If superoxide or hydrogen peroxide production is too high and completely saturates the 
reduction capability of the antioxidant enzymes, the Fenton reaction may take place. 
The reaction involves hydrogen peroxide or superoxide as substrates and, in the 
presence of  Fe2+, leads to the formation of an hydroxyl radical, which is highly 
reactive and gives a permanent accumulation of oxidative damage (D C Wallace 1999). 
 
Fe3+ +  O2
-  => Fe2+ +  O2  
                                 Fe2+ + H2O2  => Fe
3+ + OH + OH-   
 
Figure 1.9.   Fenton reaction. 
 
 
The efficiency of the defense systems normally decline with ageing, but although is 
commonly accepted the notion that oxidative damage accumulates with ageing, the 
establishment of a cause-effect relationship between the two remains controversial. In 
support of the mitochondrial theory of ageing it has been shown that overexpression of 
MnSOD in Drosophila melanogaster  was able to extent lifespan in proportion to the 
enzyme increase (Parkes et al. 1998; J Sun & J Tower 1999; Jingtao Sun et al. 2002). 
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Moreover mice expressing a mitochondria-targeted catalase showed an increased 
lifespan in association with a reduction of ROS levels, oxidative damage and age-
associated pathologies (Schriner et al. 2005).  
However, any increase of lifespan was observed in mice overexpressing human 
catalase targeted to peroxisome or nucleus, suggesting that only mitochondrial ROS 
have a role in lifespan extension (Schriner et al. 2005; A Trifunovic & N-G Larsson 
2008). In Caenorabditis elegans the treatment with small synthetic superoxide 
dismutase/catalase mimetic leads to a robust increase in life span, accompanied by a 
reduction of oxidative stress (Melov et al. 2000).  
In addition, an increase in mutations and rearrangements on mtDNA correlates with 
ageing (Douglas C Wallace 2005; Bonawitz & Shadel 2007), and microarray profiles 
showed a decline in mitochondrial-related genes (involved in metabolism, DNA repair, 
catabolism and cellular transport) with ageing in worms, flies, mice and humans 
(McCarroll et al. 2004; Zahn et al. 2006). On the other hand, a large number of 
evidences appear to be in conflict with the free radical theory as determinant in 
ageing.  
In contrast to what expected, the overexpression of the gene coding for mitochondrial 
ADP/ATP translocator (ANT) in Drosophila induces a strong reduction of ROS levels, 
without any increase in lifespan (Miwa et al. 2004). Knock-out mice for two of the main 
enzymes involved in detoxification (GPX1 and SOD2) were extremely sensitive to 
oxidative damage but their lifespan was unaffected (Holly Van Remmen et al. 2004), 
while in Caenorabditis elegans deletion of SOD2 extends lifespan increasing at the 
same time the ROS production (Van Raamsdonk & Hekimi 2009).  
 
 
1.3.2.  Mitohormesis 
Apparently there is a strong contradiction between the findings reported above, 
according to which an increase in lifespan correlates with an increase in ROS amount 
and the postulates of the free radical theory.  
The contradiction could be reconciled if we consider ROS not only acting as detrimental 
molecules but even as regulatory ones, by initiating cellular signaling that promote 
metabolic health and longevity. In fact, low levels of ROS production may exert 
downstream effects inducing stress defense mechanisms and ultimately extending 
lifespan, an adaptive response known as mitohormesis (Ristow & Schmeisser 2011). In 
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worms the exposure to various stress sources, such as heat, ROS and hypoxia extend 
lifespan (Cypser & T. E. Johnson 2002), while the immune cells for inflammatory 
response showed that the production of superoxide by NADPH oxidase is important to 
mediate the inflammasome activation (West et al. 2011).  
In yeast the reduction of TOR1 activity induces an increase of mitochondrial membrane 
potential, respiration rate and ROS production during growth phases, providing an 
adaptive signal that in stationary phase decreases ROS and increases lifespan (Y. Pan, 
E. A. Schroeder, et al. 2011). Moreover, in yeast cultures calorie restriction (reduced 
nutrients uptake) was shown to increase hydrogen peroxide levels in stationary phase, 
which in turn stimulates Sodp activity to inhibit superoxide anions accumulation and 
increase lifespan (Mesquita et al. 2010).  
 
 
 
 
Figure 1.10. Possible readouts of ROS signaling on lifespan (from Pan, 2011). 
 
Intriguingly, different hormetic ROS seems to exert their function in extending lifespan 
during different phases of yeast life; superoxide signal acts during exponential growth 
while peroxide takes action during stationary phase. Further investigations are needed 
to understand the molecular basis of that different behavior and whether or not, at 
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some point, they could converge on the same signaling pathways to influence lifespan 
(Y. Pan 2011).  
   
 
1.3.3. Ageing and somatic mtDNA mutations 
The notion that mitochondrial DNA integrity is strictly important to maintain proper 
mitochondrial function is commonly accepted. Ageing and age-associated diseases are 
accompanied by a progressive accumulation of mutations on mtDNA, despite a clear 
cause-effect relationship between the two still remains to be clarified (Douglas C 
Wallace 2005).  
The first evidence of the involvement of mtDNA damage in ageing dates back in 1988, 
when electron microscopy studies on young, adult and senescent rats showed an 
increase of structural aberrations (deletions) on senescent rats mtDNA (Pikó et al. 
1988).  
A fast growing amount of evidences appeared in the next years, showing the increase 
of mtDNA rearrangements in different human tissues with ageing, followed: in cerebral 
tissue it has been reported an age-dependent increase of somatic mutations on mtDNA 
(Corral-Debrinski et al. 1992), as well as a decline in OXPHOS function correlated with 
ageing in skeletal muscle and liver (Trounce et al. 1989; Yen et al. 1989).  
The observation that during ageing there is an accumulation of mutations does not 
clarify if mtDNA damage is a consequence of the ageing process or even the 
responsible.  
A connection between the accumulation of mutations in mtDNA and ageing was first 
established by Trifunovic and coworkers: mice expressing a mitochondrial polymerase 
deficient in proof-reading activity showed a fivefold increase in point mutations on 
mtDNA, in addition to increased deletions.  
The increase in mtDNA instability was correlated with reduced lifespan and premature 
appearance of ageing-related phenotypes such as weight loss, osteoporosis, heart 
disease and alopecia (Aleksandra Trifunovic et al. 2004). In contrast to the free radical 
theory no increased ROS production was observed in “mutator mice”, despite of a 
severe respiratory chain dysfunction (Aleksandra Trifunovic et al. 2005).  
A large body of literature claimed to refute the hypothesis of mtDNA mutations as the 
direct cause of ageing (Edgar et al. 2009; Kraytsberg et al. 2009), while other 
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evidences placed mtDNA deletions as the driving force behind the “mutator mice” 
shortened lifespan (Vermulst et al. 2008).  
In yeast, lifespan extension matches with an increased genomic stability: base 
substitution, insertions/deletions or gross chromosomal rearrangements (GCRs) both 
increase in an age-dependent manner, unless the proto-oncogene SCH9 is removed 
(Paola Fabrizio et al. 2004; Madia et al. 2008). It has been proven that SCH9 promotes 
the accumulation of superoxide-dependent DNA damage, by activating the error-prone 
Rev1-Polζ DNA polymerase complex involved in DNA repair by translesion synthesis. 
(Madia et al. 2009).  
 
 
1.4. MECHANISMS BEHIND LIFESPAN EXTENSION  
 
1.4.1.  Calorie restriction 
The only non-genetic intervention known to slow ageing and the onset of age-related 
diseases in a wide range of species such as yeast, worms, flies and rodents is calorie 
restriction (CR). The concept was first introduced in 1935 and was based on the 
assumption that lower calorie uptake would delay the biological ageing process by 
reducing cellular metabolic rate (McCay et al. 1935; Ristow & Schmeisser 2011).  
In contrast some recent findings support the notion that actually CR correlates with an 
increase in metabolic rate and ROS production both in worms and flies, inducing 
defense pathways essential for longevity (Ristow & Schmeisser 2011).  
The precisely mechanisms acting upon CR are still elusive, but many of the effects of 
CR appear to be mediated by three highly conserved signaling pathway: the TOR, 
SCH9 (AKT/S6K) and RAS/cAMP/PKA pathways integrate nutritional signals and others 
environmental cues to regulate cell growth and ageing, and are required for lifespan 
extension induced by CR (M. Wei et al. 2008).  
In yeast calorie restriction promotes both replicative lifespan (RLS) and chronological 
lifespan (CLS), the two paradigms used to measure the timing of ageing. To confirm 
the partially overlapping mechanisms mediated by CR and nutritional signaling 
pathways, it has been shown that CR fails to further increase the RLS extension 
observed in both SCH9 and TOR1 null yeast mutants.  
In yeast cultures calorie restriction is obtained by decreasing the glucose concentration 
in the media. Normally in the presence of high levels of glucose cells produce ethanol 
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by fermentation, with the result of lowering pH in the media and promote cell death. 
Switching non-dividing cell from ethanol-containing media to water mimics extreme 
starvation conditions and extends lifespan not only in a wild-type cell but even in a 
sch9∆ mutant, indicating that CR mediates lifespan extension in part by independent 
mechanisms (M. Wei et al. 2008).  
As observed among eukaryotes, one possibility is that CR may act by inducing a 
metabolic reprogramming pushing mitochondrial biogenesis and increasing 
mitochondrial bioenergetics (Lin et al. 2002; R. M. Anderson & Weindruch 2007). 
 
 
1.4.2. Longevity pathways 
Many conserved regulatory pathways have been identified as mediators of longevity 
among different organisms. The high degree of conservation of those pathways, even 
in phylogenetically distant organisms, suggests that regulation of lifespan has evolved 
early during evolution as a mechanism used by ancestral microorganisms to afford long 
period of starvation (Valter D Longo et al. 2005; Kenyon 2005).  
As pointed out before calorie restriction is one of the main interventions known to 
induce longevity in various organisms, from yeast to mammals. Genetic models to 
mimic CR have been identified and are mediated by reduction of the activity of 
glucose-signaling pathways, such as RAS/cAMP/PKA, TORC1 and SCH9 (Matt 
Kaeberlein 2010).  
In presence of glucose the RAS/PKA pathway induces cell growth and proliferation by 
transcriptional activation of many downstream effectors. The response to RAS/PKA 
signaling in part depends on the ability to prevent the activation of stress response 
transcription factors Msn2/4 (Zaman et al. 2009).  
The deletion of RAS2 or CYR1 in yeast doubles the lifespan and increases the stress 
resistance (both to heat and oxidative stress). The longevity phenotype has been 
demonstrated to be dependent on the activation of Mns2/4 and SOD (P Fabrizio et al. 
2001; Paola Fabrizio & Valter D Longo 2003). Moreover a role of RAS/PKA pathway in 
the lifespan extension has been proven even in higher organisms, such as mice and 
mammals (Migliaccio et al. 1999; Yan et al. 2007; Enns et al. 2009). 
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Figure 1.11. Mutations that reduce  AKT/PKB, TOR e RAS pathways increase lifespan in different model 
organisms (from Fontana et al., 2010).  
 
The TOR pathway is highly conserved among different organisms and stimulates cell 
growth by phosphorylating a large number of downstream effectors in response to 
nutrient availability and growth factors signals (Bonawitz et al. 2007). TOR is a 
serine/threonine kinase first identified in 90’s following the discovery of rapamycin, an 
anti-fungal compound produced by Streptomyces hygroscopicus that binds and inhibits 
both Tor1/2p (Vézina et al. 1975; Zheng et al. 1995).  
In all organisms investigated so far there is one Torp isoform that takes part in two 
distinct complexes, both nutrient responsive. The only exception is yeast, in which two 
partially redundant Tor kinases are present: Tor1/2p are part of TORC1 complex that 
positively regulate cell growth by activating transcription, translation and ribosome 
biogenesis and down-regulating autophagy, stress response and retrograde signaling; 
TORC2 complex on the other hand includes only Tor2p and is involved in cytoskeletal 
remodeling and body growth rate control (Bonawitz et al. 2007; Cybulski & Michael N 
Hall 2009). Tor2p carries out two essential functions: in TORC1, together with Tor1p, is 
required for translation initiation and G1 progression (Barbet et al. 1996), while in 
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TORC2 is required for signaling organization of the actin cytoskeleton during cell the 
cycle (Schmidt et al. 1996).  
Only the first Tor2p function is inhibited by rapamycin and in addition, TOR2 deletion is 
lethal. A large amount of literature definitely showed that mutation of TOR orthologs 
leads to increased lifespan in different organisms, such as yeast, D. melanogaster, C. 
elegans and mammals (Vellai et al. 2003; Kapahi et al. 2004; Matt Kaeberlein et al. 
2005; Polak et al. 2008; Harrison et al. 2009), suggesting an evolutionary link between 
TOR pathway and ageing.  
In yeast it has been shown that, in the presence of glucose, the inhibition of TOR1 
leads to an increase in respiratory activity sustained by an up-regulation of 
mitochondrial gene expression (Bonawitz et al. 2007). The increase of OXPHOS 
components, through the coordination of nuclear and mitochondrial genomes, allows 
to increase oxygen consumption early during growth, with the result of lowering ROS 
production and oxidative damage in ageing cultures (Y. Pan & Shadel 2009; Y. Pan, E. 
A. Schroeder, et al. 2011). A microarray analysis showed that in tor1∆ mutants a 
metabolic switch takes place, with the down-regulation of glycolytic enzymes and the 
up-regulation of TCA cycle components (Hardwick et al. 1999).  
The latter evidences point out a new role of TOR in the regulation of mitochondrial 
metabolism, suggesting that enhanced respiration is associated to longevity. In fact, 
lifespan extension of a tor1∆ mutant is comparable to a wild-type cell in a respiratory 
deficient background (Bonawitz et al. 2007). Many of TOR readouts are mediated by 
the serine/threonine kinase SCH9, the yeast ortholog of human S6K. SCH9 was first 
identified as suppressor of PKA, but more recently it has been clarified that they act in 
parallel pathways (Toda et al. 1988). 
Actually there is an additive effect  upon down-regulation of both pathways, and the 
ras2∆sch9∆ double mutant is one of the longest living. 
SCH9 is involved in mediating glucose/nutrient-dependent response including 
stimulation of cell growth and glycolysis, inhibition of stress response and regulation of 
cell size according to environmental cues (Valter D. Longo 2003). The deletion of SCH9 
extends lifespan and increases the respiration rate. However there is a discrepancy on 
the ability of SCH9 mutants to redirect the cell towards a respiratory metabolism 
because data in literature are quite controversial (Lavoie & Whiteway 2008; M. Wei et 
al. 2008; Y. Pan & Shadel 2009).  
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It has been however clearly demonstrated a role for TOR1 and SCH9 in ageing 
regulating mitochondrial function through a fine coordination of mitochondrial and 
nuclear genomes (Y. Pan 2011).  
One possibility is that TOR1 and SCH9 may act activating a downstream effector to 
promote mitochondrial biogenesis and the metabolic switch. It has been shown that 
overexpression of HAP4, a transcription factor inducing genes involved in respiratory 
metabolism, is able to increase lifespan (Lin et al. 2002; Piper et al. 2006), but the 
physical interaction SCH9 has still to be proven (Y. Pan 2011).  
A new concept emerging in literature is that the lifespan extension seems to be 
mediated, at least in part, by a reduced cytosolic translation. Despite the exact 
mechanism behind this correlation still remains unclear, many evidences are known 
(Kennedy & Matt Kaeberlein 2009; Matt Kaeberlein & Kennedy 2011). Among these a 
growing number of translation-related proteins have been identified as determinant for 
the lifespan extension, including translation initiation factors, structural components of 
ribosomes, ribosomal RNA processing factors and ribosomal proteins (Kennedy & Matt 
Kaeberlein 2009). 
Moreover, in mammals TORC1 directly controls the cytoplasmic translation through two 
downstream effectors: the phosphorylation of 4E-BP1 by TORC1 inhibits the binding 
protein and results in enhancing translation initiation, while the phosphorylation at the 
C-terminus residues of S6K activates the enzyme, which in turn promotes protein 
synthesis and ribosomal biogenesis (K. M. Hannan et al. 2003; Wullschleger et al. 
2006; Matt Kaeberlein & Kennedy 2011). Reduced 4E-BP1 and S6K orthologs activities 
correlates with increased lifespan in many invertebrates (P Fabrizio et al. 2001; Kapahi 
et al. 2004; Matt Kaeberlein et al. 2005; Henderson et al. 2006; M. Hansen et al. 2007; 
K. Z. Pan et al. 2007).  
In Drosophila a clear connection between TOR1, translation and calorie restriction has 
been reported. Upon calorie restriction 4E-BP1 protein is up-regulated and is required 
for lifespan extension and, at the same time, protein translation is addressed towards a 
specific pool of mitochondrial nuclear transcripts (and others), with simplest 5’UTRs. 
The proposed model is that upon TOR1 inactivation the reduction of global translation 
rate might coincide with a change in translation profile, towards a setting compatible 
with lifespan extension (Zid et al. 2009). 
A similar system of communication between TOR1, translation and lifespan has been 
reported in yeast long-lived strains with reduced 60S ribosomal subunit (Steffen et al. 
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2008), indicating that a change in the translation profile according to mRNA 5’UTRs 
complexity may represent a conserved mechanism to modulate lifespan extension 
according to metabolic requires (Kennedy & Matt Kaeberlein 2009).  
Moreover SCH9 promotes ribosome biogenesis and maintenance of efficient translation 
initiation, the reason why it has been proposed as a master regulator of protein 
synthesis. In fact SCH9 regulates the activities of the three nuclear RNA polymerase 
(Woiwode et al. 2008) by phosphorylating downstream effectors or by a direct binding, 
as occurs for RNA polimerase I. In this way SCH9 integrates metabolic signals 
coordinating expression, assembly and activity of the protein synthesis machinery 
(Huber et al. 2009).  
 
 
Figure 1.12. Regulatory steps and factors  involved in ribosomes biogenesis and protein synthesis under 
SCH9 control (from Huber et al., 2009).   
 
Similarly to RAS2, the SCH9 null mutant shows increased resistance to heat and 
oxidative stress, in addition to extended lifespan (M. Wei et al. 2008). Under normal 
conditions the TOR/SCH9 and RAS/PKA pathways prevent the nuclear localization of 
the transcription factor Rim15p, that promotes G0 phase entry (Pedruzzi et al. 2003; 
Cameroni et al. 2004). Upon down-regulation of these pathways or calorie restriction 
the transcription factor translocates in the nucleus, where through Mns2/4p and Gis1p 
the stress response is activated.  
The lifespan extension of SCH9 and RAS2 null mutants similarly depend on RIM15, 
while GIS1 deletion reverts ∆ras2 lifespan to a lesser extent than ∆sch9. The latter 
evidence suggests that the two major pathways TOR/SCH9 and RAS/PKA regulates the 
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longevity in a RIM15-dependent manner, but leading to different readouts in terms of 
gene transcription (M. Wei et al. 2008). In addition, under CR the lifespan extension of 
SCH9 and RAS2 null mutants only partially depend on RIM15, indicating that others 
pathways promote stress resistance and survival exist (Wei et al. 2008). 
RIM15 function contributes to lifespan extension in strains with reduced TORC1 
signaling and much of the lifespan-extending effect of sch9∆ can be attributed to 
RIM15-dependent stress response activation. 
On the other hand, SCH9 deletion can extend lifespan independently of RIM15 as well 
as sch9∆ can increase stress response by directly inducing Mns4p nuclear localization, 
without RIM15 contribution (Y. Pan, E. a Schroeder, et al. 2011).   
It is worth of note that some functions under SCH9 control are regulated independently 
of TORC1; many others sites of phosphorylation are available on SCH9 C-terminus 
even if the upstream effectors, as well as many of the downstream one, still remains 
unknown.      
 
Figure 1.13.  Longevity regulatory pathways. In yeast, nutrient-sensing pathways controlled by Sch9, 
Tor1, and Ras converge on the protein kinase Rim15. In turn, the stress response TF Msn2, Msn4, and 
Gis1 activate stress response genes and enhance cellular protection, which leads to lifespan extension. 
Although a major portion of the effect of CR on longevity appears to be mediated by the down-regulation 
of the Ras and Tor-Sch9 pathways and consequent activation of the Rim15-controlled Msn2/4 and Gis1 
protection system, additional mediators are involved (from Wei et al., 2008). 
 
 
Another important process involved in the quality control of cellular components and 
regulated by TORC1 is autophagy. TOR1 negatively regulates autophagy by direct 
phosphorylation of the autophagy related genes (ATG) or indirectly by interfering with 
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their expression at a transcriptional or translational level (C. He & Klionsky 2009). 
Reduced TOR signal leads to increased autophagy in many organisms (Noda & Ohsumi 
1998; Chang et al. 2009), and it has been demonstrated that yeast long-lived strains 
require a functional autophagy system (Alvers, Fishwick, et al. 2009; Alvers, Wood, et 
al. 2009).  
In addition, autophagy is negatively regulated even by SCH9 and RAS2; 
hyperactivation of SCH9 or constitutive activity of RAS2 leads to suppression of 
autophagy, even if TOR1 function is down-regulated. Moreover, the common 
douwnstream targets of SCH9 and RAS2, the transcription factors Mns2/4 and Rim15p, 
are required to induce autophagy upon inactivation of the two nutrient-signaling 
pathways, but not for activation upon inhibition of TOR1. These data indicate that the 
activities of TOR1, SCH9, RAS2 act in parallel to coordinate the autophagy process 
(Sampaio-Marques et al. 2011).  
 
 
1.5. YEAST AS A MODEL ORGANISM   
 
The yeast Saccharomyces cerevisiae is one of the most intensively studied model 
organisms to investigate the molecular and genetics basis of higher eukaryotes 
(Botstein 1991). Despite its simplicity, yeast shares many cellular activities with 
humans such as RNA transcription and translation, DNA replication, recombination and 
repair, proteins trafficking and metabolism (Françoise Foury & Kucej 2002). Another 
advantage of using yeast is the possibility to directly address the regulation of 
mitochondrial biogenesis, taking advantage of its behavior as a facultative 
aerobe/anaerobe.  
Yeast metabolism is regulated in accordance to carbon sources and oxygen availability. 
When grown in the presence of glucose, yeast uses glycolysis to produce ATP, while 
respiration is almost completely suppressed. When glucose is exhausted there is a 
rapid metabolic shift from fermentation toward respiration, with the induction of all the 
genes encoding for subunits responsible for oxidative phosphorylation. Although 
glucose is the preferred source, yeast is able to use other carbon sources that are not 
fermentable as glycerol, ethanol, acetate and lactate.  
All these metabolites require a proper functioning mitochondria, and are commonly 
exploited in mitochondria-related research to investigate mitochondrial dysfunctions. 
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The peculiar aspect of yeast to be a facultative aerobe renders S. cerevisiae the only 
eukaryotes able to survive even in the absence of respiratory activity. Yeast mutants 
with impairment in OXPHOS function are known as respiratory-deficient mutants (RD) 
and are unable to grow in the presence of oxidative carbon sources and dependent on 
the presence of fermentable substrates.  
The RD mutants are distinguishable from a respiratory competent strain for their 
morphology and physiology. Actually they give rise to small colonies and this is the 
reason why they are commonly known as petite mutants.  
The small size of petite mutants depend on their inability to metabolize the ethanol 
produced in culture by glucose fermentation and this consequently results in a slow 
replication rate. Petite colonies arise from mutations on genes for OXPHOS 
components encoded both by nuclear or mitochondrial genome. In the latter case it is 
possible to distinguish ρ- mutants with gross deletions on mtDNA, and ρ0 mutants with 
a complete loss of mtDNA (Dujon 1981; A Tzagoloff & Dieckmann 1990).  
 
 
1.5.1. Saccharomyces cerevisiae as a model for ageing   
Almost all of the molecular pathways that regulate mitochondrial functions and the 
ageing process are well conserved between yeast and higher eukaryotes. In addition, 
the relatively short lifespan of yeast cells and the easy ways to measure it render yeast 
extremely convenient for ageing studies. Two models have been established to 
evaluate yeast cellular ageing: the replicative lifespan (RLS) and the chronological 
lifespan (CLS). 
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Figure 1.14. Models for measure ageing in yeast (from Kaeberlein et al., 2007). 
 
RLS is defined as the number of daughter cells produced by a single mother cell before 
senescence, and it has been proposed as a model for ageing in mitotically active cells. 
Sir2, a NAD+-dependent histone deacetylase, has a key role in the regulation of RLS by 
controlling several physiologically important functions such as maintaining DNA 
integrity, silencing of telomeres and rDNA and ageing (Bitterman et al. 2003). 
Overexpression of Sir2 strongly increases RLS, while its deletion shortens the lifespan 
upon 50% (M Kaeberlein et al. 1999).  
CLS is a model of ageing of post-mitotic cells and is defined as how long yeast can 
survive in culture in a non-dividing state (Matt Kaeberlein 2010). Longevity 
interventions like calorie restriction and reduction of nutrient signaling pathways have 
been involved in the regulation of both RLS and CLS, but some of the mechanisms 
behind the two ageing paradigms seem to be different.  
It has been shown that the impairment of mitochondrial respiration only impacts CLS, 
while it has no any influence on RLS (Woo & Poyton n.d.). Our interest focused on the 
understanding of the role of mitochondrial dysfunction in ageing and on verifying a 
possible correlation between lifespan extension and increased stability of mitochondrial 
DNA. For this reason the work presented in this dissertation is focused only on the CLS 
model. 
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2.1. IMPACT OF MUTATIONS IMPAIRING MITOCHONDRIAL FUNCTION ON 
YEAST LIFESPAN 
In the past decades the understanding of the molecular mechanisms behind ageing 
became a big challenge, since ageing represents one of the major risks for many of the 
primary diseases affecting modern societies such as cardiovascular diseases, 
neurodegenerative disorders and cancer. Biological ageing is a complex multifactor 
process that converges in a progressive declining ability to respond to stress, damage 
and imbalanced homeostasis.  
Mitochondria play a central role in ageing and cellular death in many organisms, from 
yeast to humans. According to the mitochondrial theory of ageing the energetic decline 
and the production of ROS are the primary cause behind the ageing process, inducing 
damage to mitochondrial macromolecules and overwhelming stress resistance and 
repair systems (Harman 1972).  
Respiratory capacity is essential for lifespan extension as well as integrity of 
mitochondrial structure and function (D. L. Smith et al. 2007; Aerts et al. 2009).  
As pointed out by Barrientos, complementary roles of mitochondrial respiration 
capability and ROS signaling are involved in promoting cell survival. Respiration 
influences CLS mostly by altering the stress resistance response needed during 
stationary phase and the metabolism of storage nutrients (Barrientos 2012).  
Yeast strains with high level of respiration and ROS production show increased 
lifespan, while strains with low respiration and ROS have shorter CLS and may take 
advantage from additional external ROS or a pulse of ROS due to inhibition of TOR 
pathway (Y. Pan, E. A. Schroeder, et al. 2011; Ocampo et al. 2012).  
To investigate the role of mitochondrial function in yeast chronological lifespan (CLS) 
we analyzed S. cerevisiae strains impaired in different processes essential for 
mitochondrial function and biogenesis. In particular were analyzed mutants 
compromised in cellular respiration, integrity and stability of mitochondrial DNA, 
ADP/ATP transport and assembly of respiratory complexes.  
All those mutants are known to destabilize mitochondrial function and to be associated 
with many human mitochondrial pathologies. Chronological lifespan is a measure of the 
survival time of non-dividing cell. Yeast cells are usually aged in media containing 2% 
of glucose; under these conditions yeast rapidly grows by fermentation of pyruvate to 
ethanol, while cellular respiration is completely repressed in a glucose-dependent 
manner. 
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Once glucose has been exhausted a switch to a respiratory metabolism take place, cell 
growth slows and depends entirely on the ethanol accumulated in the media. 
Chronological lifespan is measured when yeast cells enter in a non-dividing state. 
 
  
2.1.1.  Mutants that compromise cellular respiration 
Among the multiple mutations know to compromise mitochondrial function, through an 
impairment of electron transport chain components, we focused our attention on 
mutants in succinate dehydrogenase (SDH) subunits and complex III assembly factor 
BCS1.  
Succinate dehydrogenase localizes to the inner mitochondrial membrane and catalyzes 
the conversion of succinate to fumarate and the reduction of ubiquinone to ubiquinol. 
This enzyme is the second complex of the electron transport chain (ETC) and the only 
one in Krebs cycle directly linked to oxidative phosphorylation.  
The succinate dehydrogenase consists of four subunits: in yeast Sdh1p and Sdh2p 
form the catalytic core, facing mitochondrial matrix while Sdh3p and Sdh4p are two 
integral membrane proteins that anchors the complex to inner mitochondrial 
membrane (Lemire & Oyedotun 2002).  
Impairment of complex II function because of mutations in SDHB, SDHC, SDHD human 
genes results in the formation of an unusual class of tumor known as paragangliamas 
(Astuti et al. 2001; Chew 2001; Douwes Dekker et al. 2003; Procaccio & Douglas C 
Wallace 2004; Raimundo et al. 2011).  
Deletions or point mutations in genes coding for SDH subunits have both been 
extensively studied in our laboratory, showing that dysfunction of SDH leads to a 
drastic loss of succinate dehydrogenase activity accompanied by inability to grow on 
non-fermentable carbon sources and almost a ~50% reduction of the respiration rate 
(Goffrini et al. 2009; Panizza et al. 2012).  
The residual respiratory activity demonstrates that the OXPHOS phenotype is 
imputable to the loss of SDH activity, impairing tricarboxylic acid cycle (TCA). Moreover 
the spectra profile of SDH mutants revealed a reduction in the absorption peak 
corresponding to cytochrome aa3, probably in relationship with a structural role of SDH 
in the stabilization of the others respiratory complexes.  
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Sdh∆ mutants show even higher hypersensitivity to oxidative damage, increased ROS 
and a pronounced mtDNA instability (Goffrini et al. 2009; Panizza et al. 2012).  
We analyzed the CLS of SDH1, SDH2, SDH4 and SDH5 null mutants in the BY4741 
background, whereas deletion of SDH3 is lethal in this genetic contest.  
SDH5 encodes for a soluble protein localized to the mitochondrial matrix required for 
the assembly of FAD cofactor with the subunit Sdh1p; deletion of SDH5 leads to a 
partial assembly of an instable complex II and a strong reduction of SDH activity, 
without compromising the other TCA or ETC enzymes (Hao et al. 2009). 
 
  
 
 
 
 
 
 
 
 
 
Figure 2.1. CLS of sdh1∆ , sdh2∆ , sdh4∆ , sdh5∆ strains in BY4741 background.  The results are the mean 
of three independent experiments. 
 
The measure of CLS shows that deletion of any of SDH subunits strongly reduces 
lifespan compared to wild-type strain, without appreciable differences between 
catalytic or structural subunits (Fig. 2.1). As expected, impairment of mitochondrial 
function correlates with premature ageing, probably dependent on the accumulation of 
oxidative damage in sdh∆ strains.  
The reduced lifespan phenotype observed seems not due to defects of respiration, that 
in SDH mutants is not completely compromised  but only reduced. As recent findings 
clarify, yeast cells have a large reserve respiratory capacity to sustain CLS, as 
respiration only shorten lifespan when reduced below a ~40% of wild-type threshold. 
Strains that respire above the threshold during exponential growth, adjust their 
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metabolic rate after diauxic shift at similar levels to that of wild-type strains, on the 
contrary strains seriously compromised that respire below the respiratory threshold in 
early phases show lower respiration rate in the stationary phase and very short CLS 
(Barrientos 2012). 
The other mutant we took into account is that devoid of the mitochondrial protein 
encoded by the gene BCS1, involved in the assembly  of the respiratory chain complex 
III.  
The protein is directly required for the assembly of the Rieske Fe-S protein, one of the 
catalytic cores, into cytochrome bc1 (Cruciat et al. 1999). It has been shown that in S. 
cerevisiae the absence of Bcs1p leads to a complete absence of growth on non-
fermentable carbon source such as ethanol, as well as a complete loss or respiratory 
capability.  
The ectopically expression of the human gene hBCS1 is able to rescue the OXPHOS 
phenotype, while no differences with the null mutant were observed when the strain is 
complemented with the pathological allele hBCS1LG129R (Tuppen et al. 2010).  
 
   
 
 
 
 
 
 
 
 
 
Figure 2.2.  The strain W303-1A bcs1∆ was transformed with pYEX plasmid carrying the wild-type human 
BCS1L (hBCS1L), the mutant allele hBCS1LG129R or the empty vector. CLS was performed growing the 
yeast cells in YNB DO-URA supplemented with 2% of glucose. After cells reached the stationary phase 
lifespan measure was performed by CFU assay, on three independent yeast cultures. 
 
We measured the CLS of both the null mutant strain (W303-1A bcs1∆) and the strains 
complemented with the human wild-type or pathological allele.  
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CLS analysis showed a reduction of lifespan for both the null mutant and the 
pathological allele, interestingly at the same extent, compared to the wild-type strain 
(Fig.2.2). This result indicates that the point-mutation is functionally equivalent to the 
complete absence of the gene, impairing in the same way complex III assembly and 
lifespan. 
 
 
2.1.2. Impairment of mitochondrial function by ADP/ATP carrier mutants 
The ADP/ATP carrier has a central role in energetic metabolism by importing ADP in to 
mitochondrial matrix and exporting ATP in cytosol. Different mutations impairing the 
ADP/ATP carrier (ANT) have been identified in humans and are responsible for adult or 
later-onset degenerative disease, autosomal dominant Progressive External 
Ophthalmoplegia (adPEO). 
Beside its role as carrier, ANT is also believed to be part of the mitochondrial 
permeability transition pore (MPTP) and could play a role in mitochondrion-mediated 
apoptosis.  
As well as in human cells, S. cerevisiae has three genes (AAC1, AAC2, AAC3) coding for 
different isoforms of the carrier (Adrian et al. 1986; Kolarov et al. 1990).  
AAC1 and AAC3 are not essential for growth on non-fermentable carbon sources and 
moreover their deletion does not impair the ADP/ATP transport (Drgon et al. 1992).  
AAC2 encodes for the most important of those carriers and is required for growth on 
non-fermentable carbon sources, such as ethanol, glycerol and lactate.  
In this work we analyzed the CLS of the AAC2 null mutant and one recessive 
pathological mutation AAC2A137D, in the WB-12 genetic background carrying a double 
knock-out aac1∆aac2∆ (Palmieri et al. 2005). 
As shown in the graph (Fig.2.3), the absence of the carrier severely compromises the 
CLS in both null and pathological mutants compared to wild-type WB-12 yeast cells. 
Interestingly the point mutation shows a lifespan reduction at the same extent as the 
null strain, despite some of the phenotypes induced by AAC2A137D mutant are more 
severe.  
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Figure 2.3. CLS of the strain WB-12 (aac1∆aac2∆) transformed with the plasmid pFL38 or with pFL38 
carrying the pathological allele AAC2A137D or the AAC2 wild-type gene. Cells were grown in YNB DO-URA 
media containing 2% glucose. The result of four biological replicates are shown. 
 
As reported in literature, AAC2 deletion leads to a complete loss of oxidative growth 
accompanied by a mild reduction of respiratory activity and respiratory complexes 
amount; on the contrary in the case of the point mutation the OXPHOS phenotype 
correlates with a complete loss of respiration and cytochromes b and aa3, but not of 
cytochrome c (Palmieri et al. 2005).  
It is worthy of note that both cytochromes b and aa3  are encoded by mtDNA while 
cytochrome c by nuclear DNA, supporting the idea that mtDNA instability may be 
involved in the pathogenicity of the AAC2A137D mutation.  
These results indicate that a defective protein can cause more damage that the 
absence of the protein itself. In fact the ATP uptake is impaired in both the null and 
pathological mutant, in which the carrier is present but catalytically inactive, and the 
reason behind differences in respiration rate and cytochromes profile need to be 
clarified.   
In addition increased oxidative damage and subsequent mitochondrial DNA instability 
was observed in the AAC2A137D mutant and authors suggest that loss of ADP/ATP 
translocation activity inhibits the ATP synthase, thereby blocking the proton influx into 
the matrix (Palmieri et al. 2005). 
As a consequence, the electrochemical gradient can increase up to a level at which 
respiration-linked proton pumping and electron flow are both stalled, resulting in 
increase of ROS and mtDNA damage (Palmieri et al. 2005).  
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In any case those mutants are a clear demonstration of the importance of proper 
functioning mitochondria to promote lifespan and support the notion of a key role of 
respiration and ROS as determinants of ageing. 
Moreover Chen et al. observed that the AAC2A128P point mutation correlates with 
membrane depolarization (inducing defects on mitochondrial biogenesis and mtDNA 
stability) and shortened replicative lifespan, and that genetic interventions that reduce 
cytosolic protein synthesis suppress the mitochondrial degeneration of the mutant. 
They suggest that decreased cytosolic synthesis rate may alleviate mitochondria from 
unassembled protein stress and reduces the proton-leakage across inner mitochondrial 
membrane (IMM) during ageing (X. Wang et al. 2008). This finding provides a link 
between protein homeostasis, cellular bioenergetics and mitochondrial maintenance 
during ageing. 
 
 
2.1.3. Mutants leading to defects on mitochondrial DNA stability  
Lifespan extension depends on genetic or non-genetic interventions that improve 
mitochondrial bioenergetics efficiency and increase stress resistance. For example 
down-regulation of TORC1 signaling pathway exerts a beneficial effect on lifespan by 
maintaining the robustness of mitochondrial function and stimulating mitochondrial 
respiration. As pointed out before the presence of a proper respiratory capacity is 
essential for lifespan extension.  
Treatment of yeast cells with ethidium bromide, a specific mtDNA intercalating agent, 
causes a pronounced instability and subsequent complete loss of mitochondrial DNA. 
The complete absence of mtDNA leads to an impairment of respiratory complexes 
assembly and as a consequence loss of respiration activity.  
We compared the CLS of a wild-type strain and ρ0 mutant in BY4741 genetic 
background (Fig.2.4) and, as expected, the mutant lifespan is strongly affected by the  
mitochondrial dysfunction resulting from the absence of mitochondrial information.   
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Figure 2.4.  Lifespan of BY4741 and BY4741 ρ0 strains in YPD media. The graph indicates the results from 
three independent experiments. 
 
Instability of mtDNA may even depend on defects in the only one mitochondrial DNA 
polymerase found in eukaryotes (pol γ), which is responsible for recombination, 
replication and repair of mitochondrial DNA.  
Over two hundred mutations in POLG have been identified in patients with 
mitochondrial disorders, including progressive external ophthalmoplegia and ataxia-
neuropathy syndrome (http://tools.niehs.nih.gov/polg/) (Copeland 2012). In yeast the 
mitochondrial DNA polymerase γ is encoded by the nuclear gene MIP1 and, conversely 
to the human ortholog, consists of one subunit (F Foury 1989).  
Deletion of MIP1 induces instability and loss of mtDNA followed by impairment of the 
assembly of complex III and IV (whose components are in part encoded by 
mitochondrial DNA) and complete absence of cellular respiration (Isaya et al. 1994; 
Baruffini et al. 2006).  
We analyzed the impact on CLS of two different MIP1 mutations, whose phenotypes 
have been previously studied in our laboratory: the first one is MIP1Y757C , a dominant 
mutation in the polymerase domain corresponding to the human POLGY955C mutation, 
while the second is a recessive mutation MIP1G224A in the exonuclease domain, 
corresponding to the human POLGg2684. The two mutations both increase point 
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mutations and deletion on mtDNA: the point mutations increases at the same extent 
for the two mutants, while deletions appear to accumulate at higher rate in the 
MIP1Y757C mutant (Baruffini et al. 2006). 
It was shown that in yeast the MIP1Y757C mutation in heterozygosity determines a 
strong increase of oxidative damage on mtDNA (Stuart et al. 2006), and in mouse the 
correspondent mutation (Y955C) induces a three-fold increase in 8-oxodeoxiguanosine 
content in mitochondrial genome (Lewis et al. 2007).  
Oxidative stress-induced defects are often turned into point mutations by error prone 
repair systems and as the last evidences suggest, this seems to be likely the reason 
behind point mutation increase in MIP1Y757C mutant strains. 
Moreover it has been shown that the high petite frequency does not depend on the 
increase in point mutations but on the increased replicative stall due to the reduction 
of the enzyme catalytic activity (Graziewicz et al. 2004).     
In any case in the MIP1Y757C mutant the high rate of mitochondrial DNA large-scale 
rearrangements is the main and primary cause behind the genomic instability 
observed. In our opinion the different inclination of the MIP1G224A , MIP1Y757C  mutants, 
towards single nucleotide or deletion defects on mtDNA, was particularly interesting to 
address the question whether mitochondrial dysfunction induced-ageing correlates with 
a specific type of damage on mtDNA. 
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B)    
Figure 2.5. CLS measure in YNB with the amino acids for the auxotrophy and glucose 2%. A) W303-1B 
mip1∆/MIP1/MIP1 and W303-1B mip1∆/MIP1/MIP1Y757C strains. B) W303-1B mip1∆/MIP1 and W303-
1B mip1∆/MIP1G224A strains.  
 
The measure of the CLS (Fig.2.5) revealed that the MIP1G224A mutation does not impact 
lifespan of yeast cells compared to wild-type, while the dominant mutation MIP1Y757C  
affects survival rate in a pronounced manner. This result suggests that large-scale 
rearrangements on mtDNA play a major role in lifespan regulation and underlines a 
tight relationship between mtDNA deletions and ageing.  
It is noteworthy that a progressive accumulation of point mutations has been shown 
with ageing in many organisms, but probably substantial amount of single mutations 
has to be reached before to severely compromise mitochondrial function, and it is 
more plausible that other types of mutations, like deletions, are more relevant for the 
ageing process.  
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3.1. ROLE OF MITOCHONDRIAL DNA DELETIONS IN AGEING  
 
Mutation on mitochondrial DNA, both deletions and point mutations, normally 
accumulate in an age-dependent manner in different organisms (Cortopassi & Arnheim 
1990; Chomyn & Giuseppe Attardi 2003; Tońska et al. 2009).  
Studies in muscle fibers from rhesus monkey having abnormalities in their ETC, 
revealed the presence of large deletions in mtDNA, suggesting that alterations in 
mitochondrial DNA (particularly deletions) lead to abnormalities in ETC function (Mao 
et al. 2012).  
Specifically, a 4997 bp deletion, flanked by direct repeats at its junctions, has been 
found as the most common deletion in ageing humans (Phadnis et al. 2005). This 
deletion was found to be common in Kearns-Sayre syndrome and chronic external 
ophthalmoplegia patients.  
At least 66% of mtDNA deletions have direct repeats at their junctions, implying that 
direct-repeat-mediated deletions give rise to these excisions. Deletions on 
mitochondrial DNA are generally due to errors during replication, but recent findings 
support the notion that large-scale rearrangements may occur even during the repair 
of damaged mtDNA (Mao et al. 2012).  
The largest number of mitochondrial DNA deletions originate as a response to a break 
in double-stranded mtDNA: the frequency at which they occur in mtDNA is higher than 
that of nuclear genome, probably depending on factors such as the proximity of 
mtDNA to the primary site of ROS production and the absence of protective histones.  
In humans, several evidences have implicated direct-repeat-mediated recombination in 
age-related instability of mitochondrial DNA (Chomyn & Giuseppe Attardi 2003; 
Phadnis et al. 2005).  
In yeast many proteins having activities consistent with a role in recombination have 
been identified; among those the protein encoded by theMHR1 gene promotes pairing 
of single-strand DNA with homologous double-strand DNA in vitro, to form 
heteroduplex joints, which are necessary intermediates of homologous recombination.  
Despite its involvement, MHR1 is not essential for recombination suggesting the 
presence of another pairing protein (Ling & Shibata 2002).  
The gene product of NUC1 was instead proposed to be required for initiation of strand 
invasion (Zassenhaus & Denniger 1994).  
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3.1.1.  Accumulation of mutations during ageing   
Integrity of mitochondrial structure and function has been proven to be fundamental 
for cell health. A decline in mitochondrial function has been observed in many ageing-
associated diseases, and loss of respiratory activity curtails lifespan in different model 
organisms.  
Previously in this dissertation we analyzed S. cerevisiae mutants compromised in 
various key mitochondrial functions and we observed that, at different extent, they 
were negatively affected in chronological lifespan.  
Ageing organisms show a progressive accumulation of mutations in their genomes. In 
particular, due to the tight relationship between mitochondrial functioning and lifespan, 
it is a common belief that mutations in mtDNA might play an important role in the 
ageing process by giving rise to cells with a decreased oxidative metabolism.  
Many evidences in higher organisms support the existence of a direct link between 
large-scale rearrangements on mtDNA and ageing or age-associated pathologies. 
Inoue and coworkers generated a mouse model carrying mutations on mitochondrial 
genome (K. Inoue et al. 2000).  
The mitochondrial-transgenic mice had various level (5-90%) of large deletions on 
mtDNA and showed the typical mitochondrial disease phenotypes with body weight 
loss, systemic ischemia, hearing loss and male infertility (Inoue et al. 2000; Nakada et 
al. 2001; Kazuto Nakada et al. 2006).  
Moreover in those mice was observed a strong correlation between the seriousness of 
the pathological phenotype and the level of deleted mitochondrial DNA (Dogan & A 
Trifunovic 2011).  
 
 
3.1.2. May longevity mutations reduce the rate of mtDNA mutability?  
As previously described, we observed that a mitochondrial polymerase mutant, that 
mainly increases deletions on mtDNA, was responsible for a pronounced decrease in 
lifespan extension. In order to clarify the relationship between ageing and 
mitochondria we decided to investigate whether increased lifespan correlates with a 
decrease in the accumulation of large-scale rearrangements on mtDNA.  
To address the question whether longevity interventions can suppress the ageing-
dependent accumulation of deletions on mtDNA we took in consideration eight 
different longevity mutants reported in literature (M. Wei et al. 2008). The genes 
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whose deletion is responsible for increased lifespan are involved in many cellular 
functions: 
 REI1: encodes for a cytoplasmic pre-60S factor required for the correct 
recycling of shuttling factors Alb1, Arx1 and Tif6 at the end of the ribosomal 
large subunits biogenesis. Is even involved in bud growth in the mitotic 
signaling network. 
 RPL6B: encodes for a N-terminal acetylated protein which is part of the 
ribosomal 60S subunit. The gene has a paralog (RPL6A) originated form a 
duplication event. 
 RPL31A: encodes for a ribosomal 60S component; loss of both Rpl31p and 
Rpl39p (another ribosomal 60S subunit protein) confers lethality.  
 TMA19: encodes for a protein that associates with ribosomes; the 
correspondent GFP-fusion protein normally localizes to the cytosol but under 
oxidative stress relocates to the mitochondrial outer membrane. 
 RPD3: encodes for an histone deacetylase that regulates transcription, 
silencing and other processes by influencing chromatin remodeling. Rpd3p 
forms at least two different complexes with distinct functions and components. 
The recruitment of the protein to the subtelomeric region is regulated by 
interaction with the arginine methyltransferase Hmt1p.   
 GPR1: encodes for a plasma membrane G protein coupled receptor that 
integrates nutritional signals to modulate cell death by the PKA pathway. 
 TOR1: encodes for a subunit of TORC1, a complex that controls cellular growth 
in response to nutrients by regulating transcription, translation, ribosome 
biogenesis, nutrient transport and autophagy. 
 SCH9: encodes for an AGC family protein kinase that regulate ribosome 
biogenesis, translation initiation and entry in G0 phase. Sch9p integrates 
nutritional and stress signals to regulate lifespan and the activation of osmo-
stress response genes. 
 
It is noteworthy that most of the selected genes, whose deletion is known to increase 
lifespan, have a direct/indirect role in the assembly or functioning of the protein 
synthesis machinery. A large number of studies showed that reduced or altered protein 
translation can promote longevity in invertebrate model organisms, and lifespan 
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extending mutations have been identified in a growing number of genes that code for 
translation-related proteins (Matt Kaeberlein & Kennedy 2011). 
All the longevity mutants have been analyzed in the S. cerevisiae haploid BY4147 
genetic context of the Euroscarf knock-out collection, with the only exception of the 
SCH9 null mutant that was deleted in our laboratory by one-step gene disruption.  
To evaluate the amount of large-scale rearrangements in mitochondrial DNA of the 
longevity mutants, the spontaneous frequency at which respiratory-deficient colonies 
(petite) arise was evaluated.  
Mutations in genes encoding for mitochondrial proteins can increase the mitochondrial 
mutability;  S. cerevisiae has the unique property to produce cells with homoplasmic 
deleted mtDNA molecules, referred as petite mutants.  
Yeast petite colonies are compromised at different extent in their mitochondrial DNA, 
which in turn results in loss of respiratory activity and the complete dependence on 
fermentative metabolism. The petite induction assay was performed at 28 °C in YP or 
SC media as described in the material and methods section.  
The petite colonies were counted after 6 days of growth and the data reported below 
are the mean of five independent experiments. 
 
 
 
 
Figure 3.1.  Effect of longevity mutations on mtDNA extended mutability. It is indicated the percentage of 
respiratory deficient colonies (petite) in the several longevity mutants. 
 
 
As shown in figure 3.1 all the longevity mutants but two (∆sch9, ∆rei1) have a petite 
frequency comparable or greater than wild-type strain. The substantial reduction of 
Percentage of  RD cells 
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spontaneous petite colonies in ∆sch9 and ∆rei1 mutants is indicative of a reduction in 
the amount of large-scale rearrangements in mitochondrial DNA, thus leading to a 
major stability of the organelle genome and mitochondrial function. The same results 
are confirmed even in minimal complete medium, albeit the percentage of petite 
colonies is quite superior for all the strains (data not show). 
The evidence that only two of the eight longevity mutations analyzed were able to 
increase mitochondrial DNA stability is an interesting result, indicating that 
maintenance of mtDNA is only one of the actors involved in the regulation of the 
ageing process and that different mechanisms cooperate to regulate lifespan extension 
in yeast.    
It is particularly interesting to observe that SCH9 and TOR1 mutants, which are known 
to be part of the same signaling pathway, behave differently: the reduced petite 
colonies frequency in the sch9∆ mutant, but not in the tor1∆ null mutant, is a quite 
remarkable result.  
Sch9p and Tor1p are part of the same signaling pathway that integrates nutritional 
cues to stimulate cell growth, and Sch9p is a downstream effector whose function is 
regulated in a TOR1 dependent manner (Y. Pan & Shadel 2009).  
Actually Sch9p has many sites of phosphorylation in the C-terminal region and only few 
of them are direct targets of TOR1 kinase, thus indicating that others unknown factors 
regulate Sch9p function.  
The evidence that tor1∆ null mutant does not reduce mitochondrial mutability suggests 
that the increase of mitochondrial DNA stability observed in sch9∆ mutant is a peculiar 
feature of SCH9 itself, and does not depend on the down-regulation of TOR1 pathway.  
 
 
3.1.3. Effect of the sch9∆ and rei1∆ mutations on induced mitochondrial 
DNA mutability    
Once observed a strong reduction of the spontaneous mutability of mtDNA  in sch9∆ 
and rei1∆ mutants, we wanted to investigate whether the two longevity mutations 
were able to increase mitochondrial DNA stability even in “high mutator” backgrounds, 
in which mutability increase is induced by different interventions. 
We first considered a genetic background in which the presence of a dominant 
mutation in the polymerase domain of MIP1 gene, encoding for the unique 
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mitochondrial DNA polymerase, was able to induce a strong increase in mtDNA 
mutability.  
The wild-type, sch9∆, rei1∆, rpl6B∆ and rpl31A∆ strains were transformed with pFL38 
plasmid containing the MIP1Y757C allele, previously produced (Baruffini et al. 2006). The 
rpl6B∆ and rpl31A∆ mutant strains were unable to reduce the spontaneous 
mitochondrial mutability and thus have been used in this experiment as a kind of 
negative controls. 
 
 
 
Figure 3.2. The percentage of RD cells in wild-type strain and longevity mutants after the introduction of 
a dominant pathological allele in mitochondrial DNA polymerase. Cells are grown in YNB DO without 
uracil. 
 
The graph shows that per se the introduction of the pathological allele determine a 
tenfold (from 3% to 30%)  increase of the petite frequency in the wild-type strain. The 
two longevity mutations sch9∆ and rei1∆ are able to maintain mtDNA stability even in 
this “highly mutator” background induced by an altered mitochondrial DNA polymerase. 
To investigate whether the longevity mutations were able to reduce the petite 
frequency independently of what is liable for it, we analyzed the effect of the two 
mutations in a second “high mutator” genetic condition due to deletion of SYM1 gene. 
SYM1 is a nuclear gene that encodes for a small mitochondrial membrane protein 
induced by heat shock (Trott & Morano 2004), whose absence leads to an OXPHOS 
defective phenotype only at 37 °C as well as a strong increase in mtDNA instability 
(around 90%) and a 40% reduction of SDH activity (Dallabona et al. 2010).  
The double knock-out mutant sch9∆sym1∆ was obtained by replacing SYM1 ORF with 
a KanMX4 cassette, coding a resistant determinant for geneticin (G418), in a sch9∆ 
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strain. The rei1∆sym1∆ mutant was obtained by crossing the haploid BY4741rei1∆ and 
BY4742sym1∆ strains, obtained by replacing the wild-type ORF with the KanMX4 
cassette. After sporulation and tetrads analysis, one non-parental tetrad carrying two 
spores able to growth in geneticin and two spores sensitive to geneticin were 
identified, and the spores rei1∆ sym1∆ were isolated. 
 
BY4741rei1       x        BY4742sym1 
KanR                                KanR 
              Parental                          Non parental                         Tetratype 
sym1 REI1   +   SYM1 REI1    -  sym1 REI1    + 
sym1 REI1   +   SYM1 REI1    -  SYM1 rei1     + 
SYM1 rei1    +   sym1 rei1   +  SYM1 REI1   + 
SYM1 rei1    +   sym1 rei1   +  sym1 rei1     + 
Figure 3.3. Tetrad analysis: is reported the genotype of the parental, non-parental tetrads and the 
tetratype and phenotype of growth in presence of geneticin (+ growth, - absence of growth).   
 
The petite assay was performed in more permissive conditions to allow OXPHOS 
defective sym1∆ cells to proliferate. Rei1∆sym1∆ and sch9∆sym1∆ were pre-grown at 
28 °C in YPE in order to counterselect the petite cells and then inoculated and 
maintained four hours at 28 °C in YP supplemented with 2% glucose. Then 2% 
ethanol was added and the cultures were shifted at 37 °C and plated after 24 and 48 
hours of growth. 
As the graphs show deletion of SCH9 and REI1 is able to drastically reduce the high 
mitochondrial DNA instability normally observed in a SYM1 mutant, both at 24 and 48 
hours of growth. According to us this result is really impressive if we consider that the 
petite frequency ranges from the 90% of the sym1∆ to the 8% of the double mutants. 
As a consequence we can affirm that sch9∆ and rei1∆ mutants act as suppressors of 
conditions that alter mtDNA stability, regardless of whether it origininates from 
mutations in mitochondrial DNA polymerase or SYM1. The beneficial effect of sch9∆ 
and rei1∆ mutations on mtDNA stability seems to be imputable to a general 
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mechanism of protection/repair rather than a mutation-specific suppression, as the 
observed rescue affects genes having different role in mitochondrial genome 
maintenance.   
  
 
 
Figure 3.4.  Analysis of mtDNA stability was performed at 37 °C in YP supplemented with 2% glucose and 
then shifted in 2% ethanol. The values reported are the mean of six independent experiments.   
 
 
Another phenotype associated with deletion of SYM1 is the reduction of succinate 
dehydrogenase activity (Dallabona et al. 2010). We observed a reduction of deletions 
on mtDNA in a rei1∆sym1∆ and sch9∆sym1∆ mutant and we wanted to address the 
question whether this phenotype correlates with an improvement of SDH activity. The 
SDH assay was performed only for sch9∆sym1∆ strain and wt, sch9∆, sym1∆ as 
controls.  
Cell were grown in YPD at 28 °C until they reached the exponential phase and then 
were transferred in stress conditions, with the addition of ethanol and growth at 37 °C, 
% petite 
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for 13 hours. Mitochondria were isolated and quantified before the assay was 
performed, as described in details in the material and methods section. 
   
 
Figure 3.5. SDH assay: the results are expressed as nmols of substrate consumed per min per mg of 
proteins. The values are the mean of four independent experiments. 
 
 
As indicated in the histogram the sch9∆sym1∆ double mutant has an intermediate 
phenotype compared to the sch9∆ and sym1∆ single mutants. Thus deletion of SCH9 
in a sym1∆ background is sufficient to increase SDH activity, but it is not obvious to 
affirm whether the improvement is a consequence of the reduced mtDNA mutability 
observed in sch9∆ mutant or depends on a general improvement of mitochondrial 
performances due to SCH9 deletion.  
However recent findings (Dallabona personal communication) proved that in a sym1∆ 
mutant the decrease of SDH activity and the instability of mitochondrial DNA depend 
on different events. In fact the overexpression of the four SDH subunits in a sym1∆ 
mutant was able to restore the SDH activity, without changing the rate of accumulation 
of large-scale rearrangements on mtDNA. This result underlined that in sym1∆ mutant 
the SDH activity and petite phenotypes result from different defects and suggest that 
the improvement of SDH activity observed in sch9∆sym1∆ double mutant is not due to 
the increase of mtDNA stability, but probably to a general well-being of sch9∆ mutant. 
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3.1.4.   Evaluation of sch9∆ and rei1∆ mitochondrial mutability during 
ageing 
Ageing associates with a progressive accumulation of mutations on DNA, as observed 
among different organisms. Previously in this dissertation we demonstrated that 
deletion of SCH9 and REI1 genes in S. cerevisiae leads to a reduced accumulation of 
deletions on mitochondrial DNA.  
To gain better insight into the connection between the longevity phenotype and the 
reduced mtDNA mutability of sch9∆  and rei1∆ mutants, we decided to clarify how and 
whether the increased mtDNA stability observed in the two mutant strains was 
changing during ageing.  
Cells from wt, sch9∆  and rei1∆ strains were pre-grown in YPD and thereafter plated; 
seven colonies for each strain were grown in YPE to counterselect the petite cells and 
the same amount of cells was inoculated in YPD and aged. After the 3 or 6 days of 
incubation cells were plated on a typical non petite counter-selection assay medium 
and incubated for seven days at 28 °C , as reported in the materials and methods 
section. 
 
Figure 3.6. Petite frequency in aged cells. The values are obtained after 3 or 6 days of cell growth.  
 
As previously observed the sch9∆ and rei1∆ mutants maintain petite frequency at 
lower levels than wt cells, and this ability is held even during ageing. Despite the 
intriguing scenario in which SCH9 and REI1 are directly involved in mtDNA stability, the 
results so far obtained might hide a different origin: one possibility is that in sch9∆ and 
rei1∆ mutants petite cells may die before than wild-type petites or that their division 
time is higher in both the mutants strains.  
Respiratory deficient cells 
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In order to assess these hypothesis and evaluate the petite cells fitness we treated wt, 
sch9∆ and rei1∆ cells with ethidium bromide to obtain the correspondent  0 mutants. A 
competition growth analysis was performed by setting up YPD cultures in which mixed 
BY4741ρ+ and BY4741ρ0, sch9∆ρ+ and  sch9∆ρ0, rei1∆ρ+ and rei1∆ρ0 cells were 
inoculated at the same concentration and grown for 24 or 48 hours (see materials and 
methods).  
 
 
 
Figure 3.7. Fitness analysis of ρ0 mutants in wild-type, sch9∆ and rei1∆ cells. Strains were plated 
immediately after their preparation, or after 24 and 48 hours. The results are the mean of tree 
independent experiments.  
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It is well known that respiratory deficient cells have a shorter lifespan compared to 
wild-type cells; the data in figure 3.7 show that the decrease in the amount of ρ0 cells 
is equivalent between the sch9∆ and rei1∆ mutants and wt, both after 24 or 48 hours 
of growth. Therefore the results suggest that the reduced mtDNA instability observed 
in the two longevity mutants does not depend on a lower fitness of their petite cells. 
To test whether a difference in the cell division time was the reason behind the low 
petite frequency, we analyzed the growth curves of ρ0 and ρ+ cells for the two 
mutants.  
 
 
 
Figure 3.8. Growth curves of ρ0 and ρ+ cells. Cells were grown in YPD at 28 °C until they reached 0.2-0.4 
OD at 600 nm. Cellular concentration was then measured every hour up to plateau.  
 
 
Per se deletion of SCH9 and REI1 alters the division time of respiratory competent 
cells: sch9∆ ρ+ cells have a slight increase in the division time compared to wt ρ+ cells 
while in rei1∆ ρ+ it doubles. A lower growth rate was observed in many others 
longevity mutants suggesting that it might be one factors involved in lifespan 
regulation.  
hours 
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If we consider the respiratory deficient cells we observe that their division time is 
increased compared to the correspondent  ρ+ cells, but the difference between ρ+ and 
ρ0 cells is quite similar for all the strains. Thus we suggest that the reduced petite 
frequency observed in sch9∆ and rei1∆ mutants during ageing is not imputable to an 
increase death rate or division time but depends on the involvement of SCH9 and REI1 
in one of the many processes that regulate mtDNA stability. 
 
 
3.1.5. Reduced mtDNA mutability mainly depends on SCH9 deletion 
Sch9p is a serine/threonine kinase that stimulates cell growth and proliferation in 
response to nutritional signals. Sch9p is a downstream effector of TOR1, but many 
others upstream regulators exist and still remain to be identified.  
We have been able to identify an increased mtDNA stability phenotype associated to 
SCH9 but not TOR1 deletion, and we wondered whether this property was imputable 
to SCH9 itself or might depend on one of the effectors that mediate and regulate SCH9 
signal.  
First of all we focused our attention on RAS2, which takes part in a pathway that works 
in parallel to SCH9 to promote cell growth and inhibit stress response activation. SCH9 
and RAS2/PKA pathways are tight in communication: Sch9p directly regulates PKA and 
SCH9 deletion enhances PKA activity (A. Zhang et al. 2011).  
Moreover it has been show that RAS2 and SCH9 deletions have an additive effect on 
CLS and that the ras2∆sch9∆ is one of the longest living yeast strains (Valter D. Longo 
2003). Based on the evidence that SCH9 and RAS2 cooperate to extend CLS we 
investigated whether the same assumption was true for mtDNA stability.  
As shown in the graph below, RAS2 deletion alone does not impact the frequency at 
which petite arise compared to wt, suggesting that mtDNA stability is specifically under 
SCH9 control. However the evidence that ras2∆sch9∆ mutant accumulates respiratory 
deficient cells at lower rate than sch9∆ is an intriguing and not obvious observation. 
The result is consistent with SCH9 and RAS2 being part of different pathways, but also 
suggests that down-regulation of all the signals that prevent stress response activation 
might be one of the mechanisms to control mtDNA integrity.  
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Figure 3.9. Mutability  strains in YP at 28 °C. Results are the mean of four independent experiments. 
 
Many of the readouts of TOR1/SCH9 pathway down-regulation depend on Rim15p, a 
kinase that induces the stress response transcription factors (Mns2/4, Gis1) and 
contributes to increase yeast lifespan. Deletion of RIM15 curtails CLS, however SCH9 
deletion is able to extend CLS independently of RIM15.  
It has been shown that many but not all of the CLS extending effect of a sch9∆ strain 
rely on RIM15 activation. To mention one case, SCH9 deletion can induce stress 
response in a RIM15-independent manner by directly inducing Msn4 nuclear 
localization (Y. Pan, E. A. Schroeder, et al. 2011).  
We tested whether the low petite phenotype of the sch9∆ strain required the presence 
of a functional active Rim15p. As shown in the graph, per se deletion of RIM15 does 
not influence petite frequency compared to a wt strain, however it reduces the 
beneficial effect of SCH9 deletion on petite mutability: the sch9∆rim15∆ mutant has a 
frequency or respiratory deficient cells halfway between the two single knock-out 
mutants. This result suggests that mtDNA stability upon SCH9 deletion partially 
% respiratory deficient colonies 
BY4741 
∆sch9 
∆sch9/∆ras2 
∆ras2 
% respiratory deficient colonies 
∆sch9/∆rim15 
∆rim15 
∆sch9 
BY4741 
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depends on RIM15, and that the same determinants of lifespan extension are in part 
involved in enhancing of mtDNA protection thus proving a link between mtDNA stability 
and CLS. 
We next addressed whether the increased mtDNA integrity in a sch9∆ strain was 
imputable to a greater availability of dNTP, a well-known limiting factor in mtDNA 
stability and copy number. The ribonucleotide reductase RNR is responsible for the 
rate-limiting step of the dNTP synthesis and is a downstream target of the 
Mec1/Rad53p kinases, thus implicating this DNA damage checkpoint in mtDNA stability 
(Lebedeva & Shadel 2007).  
The SML1 gene encodes for an inhibitor that represses RNR activity, and whose 
deletion leads to increased levels of dNTPs. Moreover SML1 deletion is able to rescue 
the high frequency of petite mutants induced by mutations on MIP1, while its 
overexpression increases mtDNA instability perhaps by limiting mtDNA repair capacity 
(Baruffini et al. 2006; Lebedeva & Shadel 2007). 
As expected per se the absence of the inhibitor is able to reduce the petite levels at 
least at the same extent of the sch9∆ strain. The double knock-out mutant shows an 
additive amelioration of mtDNA stability compared to the two single mutants 
suggesting that SCH9 and SML1 are involved in different pathways that control mtDNA 
integrity.    
 
 
 
 
 
 
 
 
 
 
Figure 3.10. Mutability  of different strains in YP at 28 °C. Results are the mean of four independent 
experiments. 
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3.1.6. SCH9 and REI1 deletion only affects mitochondrial DNA large-scale 
rearrangements 
Ageing is accompanied by a progressive decline in mitochondrial function that at least 
in part depends on the accumulation of both point mutations and large deletions on 
mitochondrial DNA.  
We demonstrated that among the longevity mutants we analyzed, only two were able 
to drastically decrease the frequency at which petite mutants arise. 
In order to address the question whether in sch9∆ and rei1∆ strains the reduction of 
large-scale rearrangements on mtDNA was accompanied by a reduced accumulation 
either of point mutations, we determinate the frequency of mutants resistant to 
erythromycin (EryR).  
Resistance to erythromycin is acquired through mutations in the mitochondrial 21S 
rRNA gene, either substitutions at positions, or G or A insertions in the gene sequence. 
Mutations conferring erythromycin resistance are always localized in the mtDNA, result 
from all types of nucleotide substitutions and do not alter the mitochondrial function 
(Baruffini et al. 2010).  
 
Strain Frequency Ery
R     
x 10
-7
 
BY4741 4,66 ± 2,32 
sch9 2,37 ± 0,89 
rei1 1,89 ± 0,43 
Table 3. Frequency of EryR mutants in longevity mutants and wild-type strain. 
 
We observed that there is no difference in the rate of accumulation of point mutations 
between the two mutants and the wt strain, suggesting that SCH9 and REI1 functions 
impact only mechanisms behind large-scale rearrangements.  
 
 
3.2. ROLE OF SCH9 AND REI1 IN PROTEIN TRANSLATION AND 
RIBOSOMAL BIOGENESIS 
 
Both SCH9 and REI1 genes have been previously reported as determinants for 
cytosolic protein synthesis, as their deletion negatively affect translation rate. Recent 
finding in many different organisms have shown that reduced cytosolic protein 
translation directly extends lifespan (X. Wang et al. 2008).  
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Chen et al. found that reduced cytosolic protein synthesis promotes mitochondrial 
maintenance and suggest that longevity interventions not only delay the onset of 
ageing associated phenotypes, but even improve increased stress resistance and 
mitochondrial bioenergetics rate (X. Wang et al. 2008).  
As previously described in details the hypothesis is that reduced cytosolic protein 
synthesis might allow to redirect the translation machinery towards a specific change in 
the set of proteins expressed, leading to alterations in the expression profile which may 
benefit cell survival. Furthermore SCH9 has been identified as a central node in 
ribosome biogenesis, since directly regulates the activity of all three RNA polymerase 
and integrates environmental cues to regulate expression, assembly and function of 
the protein synthesis machinery (Huber et al. 2009). Also REI1 is involved in ribosome 
biogenesis and function: beside its role in bud growth REI1 has been identified as a 
component of the ribosome RiBi regulon, a set of co-regulated genes that encode for 
accessory factors involved in ribosome biogenesis.  
In particular REI1 is a cytoplasmic pre-60S factor required for the correct recycling of 
shuttling factors Alb1, Arx1 and Tif6 at the final steps of the ribosomal large subunit 
biogenesis. Ribosome biogenesis is the primary occupation of growing cells, and 
represents at least the 50% of total transcription, and ribosome synthesis is regulated 
by the rate of transcription of ribosomal RNA and ribosomal proteins (Jorgensen et al. 
2004).  
Cytoplasmic ribosomes consist of two subunits: the large 60S subunit is the catalytic 
core and is made by 25S, 5.8S and 5S rRNAs and many ribosomal proteins, while the 
small 40S subunit consists only of 18S rRNA associated with many ribosomal proteins 
(RP). To ensure the proper transcription, processing and assembly of the 78 RP and 
rRNAs that constitute a ribosome, a large number of accessory factors (RiBi) are 
required (Huber et al. 2011). The RiBi regulon includes not only genes involved in the 
assembly and modification of rRNAs and RP but even subunits of RNA polymerase I 
and III, tRNA synthase and translation factors (Fatica & Tollervey 2002; Jorgensen et 
al. 2002).  
To limit energetic dissipation under stress or starvation conditions, the synthesis of 
ribosomal components and factors involved in their biogenesis need to be tightly 
regulated. This regulation is in part dependent on the nutritional signaling pathways 
TOR/SCH9 and RAS/PKA.  
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In particular it has been shown that sch9p by phosphorylating the transcriptional 
repressors Stb3, Dot6 and Tod6 is able to antagonize their ability to inhibit RiBi genes 
transcription (Huber et al. 2011). Downregulation of RiBi genes transcription severely 
impairs ribosome synthesis, leading to an accumulation of precursors components and 
lowering the cytoplasmic synthesis rate.  
There is a tight relationship between cytosolic protein synthesis and mitochondrial 
function, as many of the mitochondrial proteins involved in mtDNA replication and 
maintenance (among those the mitochondrial DNA polymerase), in mitochondrial 
transcription and translation or proteins involved in key mitochondrial metabolic 
pathways such as the Krebs cycle, are encoded by nuclear genes. Mitochondrial 
respiration itself requires a coordination between nuclear and mitochondrial genomes 
as many of the components and assembly factors, required for a proper respiratory 
capability, are encoded in the nucleus.  
Thus it is not unexpected that regulation of RiBi genes expression has an impact on 
mitochondrial function. Considering that many longevity mutations have shown 
reduced cytosolic protein synthesis, we suggest that probably lowering the 
translational rate is one of the mechanism to improve mitochondrial function by 
enhancing quality control of respiratory complexes assembly or by reducing the 
occurrence of mutations on mitochondrial DNA or both.  
To assess whether the decrease in cytoplasmic translation rate was accompanied by a 
downregulation of ribosome components transcription we performed a Northern blot 
analysis in longevity mutants sch9∆ and rei1∆. We decided to investigate the 
transcription levels only for the two  rRNAs 25S and 5S and the reason is that 25S, 18S 
and 5.8S are transcribed by RNA polymerase I as a single transcription unit, whereas 
5S rRNA is transcribed independently by RNA polymerase III. 
Total RNA were extracted from sch9∆ and rei1∆ strains, quantified, separated by 
electrophoresis in a formaldehyde gel and then transferred to a nylon membrane, 
through a capillarity blotting system. Thereafter the membrane was incubated 
overnight with probes labeled with P32 complementary to 25S and 5S rRNAs and 
signals were detected by autoradiography (see materials and methods section).  
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Figure 3.11. Northern blot to test the expression levels of 25S and 5S rRNA in longevity mutants. The 
analysis was performed in exponential growth phase of yeast cells and the transcription signal from 
sch9∆ and rei1∆ strains is normalized to wild-type. 
 
 
As reported in Fig.3.11 both strains show a reduction in the transcripts amount, 
suggesting that reduced cytosolic protein synthesis rate is regulated also at 
transcriptional levels in sch9∆ and rei1∆ mutants. The results show a major reduction 
of transcription relative to 5S rRNA, suggesting that transcription regulation primarily 
or mainly impacts RNA polymerase III. This is an interesting data considering that RNA 
polymerase III is responsible also for tRNA genes transcription, whose reduction 
impinges directly on translation efficiency.  
SCH9 and REI1 are directly involved in the proper functioning of the cytosolic 
translation machinery. On the basis of the regulatory role exerted by SCH9 on RiBi 
regulon transcription and the notion that REI1 belongs to the RiBi genes class, we 
investigated whether deletion of other genes involved in ribosome biogenesis was able 
to increase the stability of mitochondrial DNA.  
In yeast at least  200 genes are grouped into the RiBi regulon: we first screened the 
list by taking into account the genes whose deletion was not lethal, and among those 
we selected the genes that were available in our Euroscarf knock-out collection. Finally 
we selected seven RiBi genes holding as much as possible different functions in 
ribosome biogenesis. The genes we took into account for our analysis are listed below: 
 
 NOP6: encodes for a protein required for 40S ribosomal subunit biogenesis. 
Deletion of NOP6 leads to a reduced 18S amount because of the inhibition of 
the rRNA precursor processing and increased glycogen accumulation. 
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 RRP8: encodes a nucleolar protein involved in rRNA processing by pre-rRNA 
cleavage at site A2. The protein is also involved in telomere maintenance and 
deletion of the gene lead to increased telomere length and decreased cell size. 
 SLX9: encodes for a protein that associate with the 90S pre-ribosome and 43S 
small ribosomal subunit precursor. Deletion of the gene leads to increased 20S 
pre-rRNA accumulation, decrease of the mature 18S rRNA, increased heat 
sensitivity and decreased nuclear export and exponential growth rate. 
 ARX1: encodes for a protein involved in the biogenesis of ribosomal large subunit 
biogenesis. Arx1p is a shuttling factor associated with the ribosomal export complex 
that translocates the pre-60S complex from the nucleus to the cytoplasm. In 
addition the protein interacts directly with Alb1 and is responsible for Tif6 recycling 
defects in absence of Rei1. 
 NSR1: encodes for a nucleolar protein that binds nuclear localization 
sequences and is required for pre-rRNA processing and ribosome biogenesis. 
Deletion of the gene leads to a reduction in the synthesis of the 40S subunit 
and is associated with decreased oxidative stress resistance and extended 
lifespan. 
 MRT4: encodes a protein that localizes to the nucleolus and is involved in mRNA 
turnover and ribosome assembly. The deletion of the gene delays the accumulation 
of the mature 25S and as a consequence decreases the amount of 60S subunit. 
 PUF6: encodes for a protein that  co-sediments with the 60S ribosomal subunit 
and is required for its biogenesis. 
 
 
Figure 3.12. Percentage of respiratory deficient cells in various mutants involved in ribosomal biogenesis. 
The value of a wild-type strain has been referred as 100% and the mutants are compared to that value. 
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We measured the petite frequency of yeast strains deleted in those RiBi genes by a 
petite  assay in YP medium at 28 °C. Among the genes we analyzed three were able to 
strongly reduce the accumulation of large-scale rearrangements on mitochondrial DNA.  
This result is really promising if we consider that almost half of the mutants analyzed 
show an increased mtDNA stability and suggests again a tight connection between 
cytoplasmic protein synthesis and mitochondrial function. Altogether the results 
obtained suggest that there are others genetic conditions that that impact cytoplasmic 
translation rate and reduce mitochondrial DNA instability and it will be relevant to 
determine whether deletion of the three RiBi genes even positively influences lifespan 
extension.  
 
 
3.3. SCH9 AND REI1 PROMOTE LIFESPAN EXTENSION AND 
MITOCHONDRIAL DNA STABILITY BY DIFFERENT MECHANISMS 
 
Part of the work described in this section was carried out under the supervision of Prof.  
Gerald Shadel at Yale University School of Medicine department of Pathology, during 
the six months I spent in his laboratory. 
 
 
3.3.1. Sch9∆ and rei1∆ mutants differently modulate mitochondrial 
function 
As reported from many studies in different model organisms, lifespan extension 
correlates with an efficient respiratory activity and in yeast it has been proven that 
strains with the highest respiratory rate are the longest living (Bonawitz et al. 2006). 
Deletion of TOR1, impacting one of the key nutritional signaling pathways involved in 
lifespan extension, almost doubles oxygen consumption compared to a wild-type strain 
and the increased respiration rate is required for full lifespan extension.  
In fact it has been shown that in cells unable to respire there is no difference in 
lifespan between a tor1∆ mutant and a wt strain (Bonawitz et al. 2007). To determine 
whether increased respiratory rate was a property shared by our long-lived mutants 
sch9∆ and rei1∆ we recorded oxygen consumption on whole cells, as described in 
material and methods section.  
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The measure of respiration rate is a convenient method to evaluate the real 
functionality of mitochondrial respiratory complexes.  
 
Figure 3.13.  Respiratory rate of strains grown until early stationary phase in YP supplemented with low 
glucose (0.6%). The values are expressed as nmol O2*min
-1*(mg dry weight)-1 and standard deviation of 
four biological replicates normalized to wild-type is shown.  
 
Both the mutants show an increase in their respiratory ability compared to wild-type.  
In principle the increased respiratory activity we observed might depend on either an 
higher mitochondrial content per cell or on an increased amount of respiratory 
complexes in the sch9∆ and rei1∆ mutants. To evaluate this hypothesis we determined 
the mtDNA copy number in sch9∆ and rei1∆  null mutant, in accordance to the 
evidence that usually the amount of mitochondrial DNA correlates with the 
mitochondrial abundance.  
Mitochondrial DNA copy number was determined by RT-PCR and measured as the ratio 
of the mitochondrial gene target COX1 relative to the nuclear gene target ACT1. 
 
 
Figure 3.14. Mitochondrial DNA copy number in wild-type and longevity mutants strains determined by 
qRT-PCR. 
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No significant differences in mtDNA amount were found suggesting that the increased 
respiration rate is imputable to higher OXPHOS complexes density rather than an 
increase in mitochondrial biogenesis.  
Shadel and coworkers previously demonstrated that downregulation of TORC1 pathway 
induces high respiration rate through upregulation of the OXPHOS machinery, that 
results from an increased mitochondrial gene expression.  
They suggest the TORC1 normally is required to repress mitochondrial gene expression 
and respiration in the presence of glucose and that in a tor1∆ strain derepression of 
respiration is implicated in lifespan extension (Y. Pan & Shadel 2009).  
Moreover they found that during early growth stages the increased respiration coupled 
with ATP production induces an increase in mitochondrial membrane potential and as a 
consequence a ROS production. The elevated levels of ROS during growth act as an 
adaptive mitochondrial signal that promote longevity in stationary phase by reducing 
both membrane potential and ROS amount (Y. Pan, E. a Schroeder, et al. 2011).  
We decided to evaluate whether the increased respiration of the sch9∆ and rei1∆ 
longevity mutants also in our genetic background was accompanied by changes in 
mitochondrial properties and the same adaptive response observed by Pan et al..  
We measured mitochondrial membrane potential and ROS production during 
exponential and stationary growth phases by FACS analysis. Cells were grown both in 
YPD or SC medium and then incubated with different dyes: DiOC6 was used to 
measure mitochondrial membrane potential, while DHE to measure ROS content. 
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Figure 3.15. FACS analysis of wild-type and SCH9 and REI1 null strains stained with DiOC6 or DHE. The 
values are the mean of six independent biological replicates. 
During exponential growth both sch9∆ and rei1∆ mutants show an increased 
mitochondrial membrane potential compared to wild-type strain, that in turn is 
significantly lowered during stationary phase only in the sch9∆ null mutant.  
Moreover the high mitochondrial membrane potential of the sch9∆ mutant during early 
stages of growth leads to an increase in ROS production, that is considerably reduced 
during stationary phase.  
Contrariwise the rei1∆ mutant has a quite constant membrane potential during all the 
stages of growth, while ROS accumulate with ageing.  
This result suggests that only deletion of SCH9 leads to an increase of ROS production 
early during growth to promote an adaptive signal that stimulates lifespan extension 
and reduces oxidative damage in stationary cells.  
Our hypothesis is that the pulse of ROS during exponential growth was able to induce 
a reorganization of gene expression activating a stress response cell program that 
lowers ROS accumulation in stationary phase, protects yeast cells from accumulation of 
mutations on mitochondrial DNA and as final result promotes longevity.  
Therefore SDS-PAGE was performed to evaluate the levels of the mitochondrial 
superoxide dismutase SOD2 in the sch9∆ and rei1∆  null mutants. Mitochondria were 
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extracted as described in materials and methods section and quantified by Bradford 
assay.  
40 µg of mitochondria for each strain were separated on a 12% polyacrylamide gel and 
transferred to a nitrocellulose membrane.  
Western Blot with Anti-Sod2p was performed and immunoblot for the mitochondrial 
outer membrane protein porin was used to show equivalent protein loads per lane 
(Fig.3.16). 
 
 
Figure 3.16. SDS-PAGE Western Blot of sch9∆ and rei1∆ mutants and BY4741 in exponential or stationary 
growth phase. 
In agreement with our hypothesis, the ROS adaptive signal observed in the sch9∆ null 
mutant induces an increase in the amount of Sod2p, which is mild during exponential 
growth and relevant during stationary phase.  
The different amount of the protein during the two growth phases could be explained 
as the induction of a rapid response to the ROS pulse initiated early during cell growth 
that is finally accomplished in stationary phase.  
The increased amount of Sod2p suggests that activation of stress response genes in 
sch9∆ null mutant is crucial to prevent mitochondrial damage and dysfunction and to 
promote longevity.  
In the case of rei1∆, the Western Blot reveals a mild increase in  Sod2p levels during 
exponential growth compared to wt, which is completely lose in stationary phase.  
This result suggests once more that the mechanism by which deletion of REI1 
positively influences mtDNA stability and lifespan is completely different from that of 
SCH9.  
It is noteworthy to mention that SCH9 is part of a well-known pathway involved in the 
regulation of stress response genes, while REI1 encodes for a protein involved in 
ribosome biogenesis and its role in lifespan extension is still elusive.  
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On the other hand many genes encoding for proteins involved in protein translation 
machinery assembly or regulation have been actually identified as determinants for 
longevity, probably because they have different functions beside their primary role in 
protein synthesis. 
To prove that the increase of ROS in sch9∆ strain during exponential growth was 
acting exclusively as a signal and did not induce oxidative damage inside the cell, we 
performed an aconitase activity assay. Aconitase is a mitochondrial enzyme that 
isomerizes citrate to isocitrate, a key intermediate of the Krebs cycle.  
Measure of aconitase activity can be used as an intracellular sensor of oxidative 
damage since the enzyme can be reversibly inactivated through the oxidation of its Fe-
S cluster.  
In general measure of aconitase activity during different stages of CLS is indicative of 
superoxide levels in ageing yeast (Paola Fabrizio & Valter D Longo 2003). Cells were 
grown in YPD at 28 °C until late exponential growth was reached (OD 1) and the assay 
was performed as described in the material and methods.  
We observed no significant differences between the sch9∆ null mutant and the wild-
type strain, indicating that the pulse of ROS is not responsible for induction of oxidative 
damage (Fig.3.17). Moreover we performed a Dot Blot assay on total DNA from sch9∆ 
null mutant and its parental strain BY4741 to measure the level of 8-oxoguanosine, the 
major modification on DNA induced by oxidative damage.  
Total cellular DNA extracted from the mutant and wild-type strain and treated with 
proteinase K and RNAse to eliminate any contamination, was quantified at nanodrop 
and aliquots of 5-10 µg were diluted in TE buffer.  
The mixture was then applied directly on a nylon membrane as a dot and after 
membrane was dried one hour at 55° C. From that moment the nylon membrane was 
treated as a normal Western Blot membrane and incubated with Anti-8-oxoguanosine 
antibody.  
 
74 
 
 
Figure 3.17. Aconitase activity assay on mitochondrial and Dot Blot assay on total DNA from sch9∆ and 
wild-type strains during exponential growth. Dot Blot signal was normalized to the amount of 
membrane-bound DNA measured as intensity of the dot after staining with methylene blue.  
 
As shown in figure 3.17 the amount of 8-oxoguanosine is similar between sch9∆ 
mutant and the wild-type strain, confirming that the increase of ROS does not induce 
oxidative damage but only activate stress defense systems to promote longevity.  
As previously discussed both sch9∆ and rei1∆ strains showed an increased respiratory 
rate compared to a wt that was not imputable to an increased mitochondrial 
biogenesis.  
In order to investigate whether higher OXPHOS complexes density was responsible for 
the increased respiratory activity we performed a Western Blot analysis on whole cell 
extracts from sch9∆ and rei1∆ strains.  
The same amount of total cell extract for each strain was loaded on a 15% 
polyacrilamide gel and transferred to a PVDF membrane. The latter was then incubated 
with Anti-Cox2p, Anti-Cox3p and Anti-Cox4p antibodies, while the immunoblot for porin 
was used to normalize samples loading.  
Cox2p and Cox3p are subunits of cytochrome oxidase complex encoded by 
mitochondrial DNA while Cox4p is encoded by nuclear DNA. 
In agreement with the increased respiration activity we observe an increase in the 
steady-state levels of cytochrome oxidase subunits Cox2p and Cox3p and a mild 
increase in Cox4p, respectively encoded by mtDNA and nuclear genome, but no 
increase in porin level was observed (Fig.3.18). The increase in OXPHOS components 
density was observed only in sch9∆ mutant both in YPD, YPGal or SD, but not for rei1∆ 
null strain (data not show).  
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Figure 3.18. On the left Western Blot on whole cell extracts from sch9∆ and BY4741 in exponential grow 
phase. On the right cytochromes spectra profile on intact cells in early stationary phase.  
 
This result suggests that deletion of SCH9 is able to up-regulate OXPHOS expression to 
improve mitochondrial respiration without any effect on mitochondrial biogenesis. In 
fact no differences in actin:porin ratio (normally used as indicator of mitochondrial 
content)  was observed confirming data relative to mtDNA copy number.  
Moreover the cytochromes spectra profile, which is an index of the structural integrity 
of the respiratory chain complexes, showed an increase in all three cytochromes 
content in sch9∆ cells and particularly prominent in the case of cytochrome aa3. This 
result furthermore support the Western Blot result and the idea that increased 
respiratory rate is sustained by an up-regulation of respiratory subunits. 
Consistent with the results discussed above, we performed a mitochondrial translation 
assay using a standard in vivo labeling approach (described in details in materials and 
methods) to measure mitochondrial proteins synthesis rate, expected to be increased. 
Late exponential phase cells grown at 28 °C from sch9∆ and its parental strain BY4741 
were treated with cycloheximide to inhibit cytoplasmic translation and then incubated 
with S35-labeled methionine to measure the incorporation rate in proteins encoded by 
mtDNA.  
After 15’ of incubation with the S35-labeled methionine (pulse), cells were incubated for 
30’ or 60’ with unlabeled methionine (chase) in order to evaluate also mtDNA encoded 
proteins stability over the time.  
Loading control is performed by staining of the dried gel with Comassie blue (data not 
shown, see materials and methods).  
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Figure 3.19. MPS analysis. An equivalent of 0.6 OD of cells grown until late exponential growth was 
labeled for 10 minutes with S35-labeled methionine (pulse), and later incubated for 30’ or 60’ with 
unlabeled methionine (chase). Total proteins were extracted and precipitated with TCA and then resolved 
in SDS-PAGE 17.5%. Autoradiography of MPS analysis for about 15 hrs is shown.  
 
 
No difference either in translation rate (pulse) or proteins stability (chase) was 
observed between the wild-type and sch9∆ null strain. This result seems contradictory 
considering the increased amount of mtDNA-encoded COX components observed by 
Western blot analysis. We speculate that the different division time between SCH9 and 
sch9∆ null cells might be the reason behind this result. Indeed, as previously described 
in this dissertation sch9∆ cells grow slower than wild-type cells to such an extent that 
during the 10 minutes of incubation with S35-labeled methionine the translation rate of 
the mutant strain is per se lower than that of wild-type cells.  
Therefore, it seems reasonable that longer incubation time with S35-labeled methionine 
could be necessary to picture the real amount of mitochondrial protein translation in  
sch9∆ null strain. Normally in a wild-type strain after 20 minutes of incubation with S35-
labeled methionine no more radioactivity is incorporated and the steady-state level of 
neo- synthesized proteins is reached.  
We speculate that incubation of wild-type and sch9∆ cells for at least 30 minutes will 
allow us to eliminate differences imputable to delayed growth rate of sch9∆ mutant. 
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3.3.2. Induction of nucleoids components is responsible for increased 
mtDNA stability in REI1 null mutant  
Both nuclear and mitochondrial DNA are constantly exposed to exogenous and 
endogenous agents that induce damage and instability. ROS, generated inside of 
mitochondria, are the primary source of oxidative damage in the cell and a responsible 
for many lesions on DNA such as single/double strand breaks, abasic site formation 
and accumulation of oxidized bases.  
Accumulation of DNA damage leads to impairment of DNA replication and transcription, 
chromosomal rearrangements and general genomic instability (Gredilla et al. 2010). 
Mitochondrial DNA is particularly susceptible to oxidative damage because of its 
proximity to the main site of ROS production, the absence of a nucleosome-like 
structure to protect mtDNA and the exiguity of mtDNA damage response pathways 
compared to the ones present in the nucleus (Rourke et al. 2002).  
In fact, the steady-state levels of oxidative induced lesions observed in mtDNA can be 
several-fold higher than those in nDNA (Barja & Herrero 2000; Hamilton et al. 2001). 
DNA damage is believed to play an important role in the ageing process and the 
functional decline observed in many tissues during ageing has been associate in 
particular to mtDNA integrity (Gredilla et al. 2010).  
Recently many evidences suggest that many of the nuclear repair mechanisms actively 
function even in mitochondria, stressing their importance in maintenance of genome 
integrity. One example is given by the nucleotide excision repair (NER) system that 
repairs lesions such as alkylation or oxidation induced by ROS and are systematically 
shuttled between mitochondria and nucleus depending on where the site of damage is 
localized. 
Mitochondrial DNA is protected from oxidative damage by the packing in a structure 
known as nucleoid, which is found to be associated with the inner mitochondrial 
membrane.  
In yeast nucleoid is made up by at least 22 different proteins involved directly in 
mtDNA maintenance or even in metabolic pathways. The latter characteristic renders 
nucleoid a dynamic structure that is able to change in accordance to metabolic cues 
and regulate mtDNA maintenance depending on the nutritional conditions (for more 
details see 1.1.3 section).  
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Mitochondrial DNA stability relies on the activity of 24 proteins involved in nucleoid 
organization and 35 proteins involved in mitochondrial genome maintenance. We 
investigated whether the reduced content of large-scale rearrangements observed in 
our longevity mutants sch9∆ and rei1∆ was dependent on increased gene expression 
of the components responsible for mtDNA stability.  
Among the two lists of gene involved in nucleoid or mtDNA maintenance we focused 
our attention on three of them that belong to both categories, ABF2, ACO1 and ILV5. 
Ilvp and Aco1p are metabolic enzymes respectively involved in aminoacids biosynthesis 
and Krebs cycle while Abf2p is involved directly in mtDNA stability and recombination. 
A Northern Blot analysis was performed on total RNA from sch9∆ and rei1∆ mutants 
and their parental strain. 
 
Figure 3.20. Northern Blot assay to identify the expression levels of genes involved in mtDNA stability. 
As shown in figure 3.20 only the rei1∆ null mutant shows an increase in the amount of 
transcription of the target genes. In particular the increased is prominent for ILV5 and 
less pronounced for ACO1 and ABF2.  
This result suggests that the reduced instability observed in rei1∆ mutant is mediated 
by an increased protection of mtDNA from oxidative damage due to a more efficient 
packing in a nucleoid structure.  
The strong induction of ILV5 is quite an interesting result because in general upon 
aminoacids starvation Ilv5p mediates redistribution of mtDNA molecules into new 
nucleoid structure (without net DNA synthesis), increasing nucleoids number and 
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improving the probability that daughter cells inherit a full complement of mtDNA (Kucej 
et al. 2008).  
To gain a better understanding of the link between REI1 deletion and ILV5 
overexpression one possibility is to investigate whether rei1∆ null mutant is able to 
mimic aminoacids starvation conditions to increase ILV5 expression.  
Aco1p and Abf2p are physically able to bind mtDNA and it was shown that Aco1p is 
essential for mtDNA maintenance even in the presence of Abf2, suggesting that the 
proteins have separate functions (Chen & Butow 2005). Abf2p abundance regulates 
nucleoid compaction and mtDNA recombination while Aco1p directly controls 
replication, recombination and repair of mitochondrial genome. 
Furthermore it was shown that Aco1p expression is induced by the heme activator 
protein (HAP) system which is most active in cells with pronounced respiratory activity, 
which is the case of rei1∆ mutant, and under these conditions mtDNA transcription and 
recombination were induced (X. J. Chen et al. 2007). 
It will be interesting to evaluate whether the increased gene expression of ABF2, ACO1 
and ILV5 corresponds to an increased content of the correspondent proteins in REI1 
null cells. 
Overall these results suggest that reduced mtDNA rearrangement and increased 
respiratory activity upon REI1 deletion depend on a completely different mechanism 
from the adaptive response observed in sch9∆ mutant, and appear to rely on a direct 
stabilization of mitochondrial DNA through overexpression of nucleoid components.  
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CHAPTER IV 
 
           Functional role of HCCS deficiency in the development of 
microphthalmia with linear skin defects syndrome 
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4.1. DOMINANT MICROPHTHALMIA WITH LINEAR SKIN DEFECTS 
SYNDROME 
 
The work described below originates from a collaboration between our research team 
and the group of Prof. Brunella Franco at the Telethon Institute of Genetics and 
Medicine (TIGEM) of Naples. We performed analysis in the yeast S. cerevisiae while 
our coworkers used the medaka fish as model organism to get a better understanding 
of the biochemical functional effects of HCCS deficiency and its pathological mutations 
in the development of MLS syndrome. The work has been published and it is available 
in the issue 1, volume 5 of EMBO Molecular Medicine Journal 
(http://onlinelibrary.wiley.com/doi/10.1002/emmm.201201739/pdf). 
 
 
4.1.1. Clinical feature of MLS patients 
Microphthalmia with linear skin defects syndrome (MLS), also known as MIDAS 
(microphthalmia, dermal aplasia, and sclerocornea), is a rare X-linked dominant 
neurodevelopmental disorder associated with in utero males lethality. Affected females 
at birth show anophthalmia or unilateral/bilateral microphthalmia and linear skin 
defects, which are limited to the face and neck.  
Additional features that characterize the syndrome are sclerocornea, chorioretinal 
abnormalities, infantile seizures, congenital heart defect and mental retardation 
(Wimplinger et al. 2006). The disorder is caused by deletions that results in segmental 
monosomy in the Xp22 chromosomal region.  
Three different genes are present in the critical region such as MID1, HCCS and  
ARHGADP6: MID1 was found to be mutated in patients affected by Opitz G/BB 
syndrome whereas no diseases where previously associated to mutations in the others 
two genes. Wimplinger and coworkers provided for the first time the evidence of HCCS 
complete or partial deletion and/or loss of function point mutations in patients affected 
by MLS, thus suggesting its involvement in the appearance of the disease (Wimplinger 
et al. 2006).  
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Figure 4.1. Schematic representation of the minimal critical region for MLS (from Wimplinger et al., 
2006). 
 
HCCS is an highly conserved gene, ubiquitously expressed, that encodes for a 
mitochondrial holocytochrome c–type synthase, also known as “heme lyase”. The 
enzyme catalyzes the covalent attachment of heme to both apocytochrome c and c1, 
leading to the mature forms, which are necessary for proper functioning of the 
mitochondrial respiratory chain (Prakash et al. 2002). In addition to its role in oxidative 
phosphorylation (OXPHOS), cytochrome c is important to mediate caspase-dependent 
cell death (apoptosis), in response to a variety of death-promoting stimuli. 
MLS has an incidence of 1/5000 newborn and a high intra and inter-familiar variability 
has been reported, although it does not correlate with the extent of the deletion in the 
Xp22 chromosomal region (Wimplinger et al. 2007).  
A few patients for example show only the ocular defects without any skin lesion while 
others present only dermal defect. The variability observed among patients was 
suggested to depend on the influence that the pattern of X inactivation may play in the 
development of the various clinical manifestations that characterize MLS (Wimplinger 
et al. 2007).  
Heterozygous loss of function mutations in the HCCS gene have been reported in 
patients with MLS phenotype but normal karyotype. Our coworkers have previously 
reported two different mutations in two female patients from the same family, a 
heterozygous c.589C=>T (p.R197X) nonsense mutation in exon 6, as well as a 
heterozygous c.649C0>T (p.R217C) missense mutation in exon 7 of the HCCS gene.  
The patient with the R197X mutation shows the classical MLS phenotype, while the 
sister with the R217C mutation presented bilateral microphthalmia and sclerocornea, 
but no linear skin defects.  
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Figure 4.2. Alignment of heme lyases protein sequence between 207-217 position among various species. 
The region of the protein aligned is given in figure and conserved amino acids are shown in bold while 
the arginine at position 217 is shaded in grey and included in the red box.  
 
The missense mutation impacts an highly conserved arginine residue at position 217 of 
the HCCS protein, suggesting an important role of this amino acid in heme lyase 
function. In contrast, the nonsense mutation found in the other patient causes a 
premature stop located 21 nt upstream of the last splicing-generated exon-exon 
junction, which is responsible for the presence of an HCCS protein lacking 72 C-
terminal amino acids (D197–268) (Wimplinger et al. 2006).  
Moreover another heterozygous missense mutation c.475G=>A/p.E159K was found in 
a single female patient with bilateral microphthalmia and sclerocornea in both eyes. 
The E159K mutation converts an highly conserved glutamate residue to lysine, in a 
region which is responsible for the import of the heme lyase into the intermembrane 
space of mitochondria.  
 
 
 
 
 
 
 
 
Figure 4.3. Alignment of heme lyases protein sequence between 151-169 amino acids, among various 
species. The conserved amino acids are shown in bold while the glutamate at position 159 is shaded in 
grey and included in the red box.  
 
 
 
84 
 
In heme lyases the targeting sequence consists of about 60 amino acids residues 
which constitute two highly conserved motifs, from residues 151-169 and 190-216 of 
human HCCS. Experiments carried out in human cells showed that HCCS E159K 
mutation does not impair the translocation of the mutated heme lyase to mitochondria 
(Wimplinger et al. 2007). Similarly the HCCS R217C protein was found to be localized 
into mitochondrial while the truncated form (HCCS D197–268) was diffusely dispersed 
in the cell, suggesting that the last 72 C-terminal amino acids residues are important 
for mitochondrial targeting (Wimplinger et al. 2006).  
Unlike higher eukaryotes, which hold only one heme lyase responsible for the 
maturation of both cytochrome c and c1, in the yeast Saccharomyces cerevisiae two 
different heme lyases are present: the enzyme encoded by the gene CYC3 is strictly 
specific toward cytochrome c, while the enzyme encoded by the gene CYT2 is active 
toward cytochrome c1. Due to their essential role in electron transfer chain it is not 
surprising that the absence of the mature forms of both cytochrome c and c1 lead to a 
complete loss of the respiratory capability (Bernard et al. 2003).  
As previously described the strain B8025 deleted in CYC3 is unable to grow on non-
fermentable carbon sources indicating a severely depleted respiratory function 
(Dumont et al., 1987). While ectopic expression of human HCCS wild-type is able to 
restore respiratory function, expression of HCCS mutants associated with MLS (HCCS 
E159K; HCCS R217C) did not complement the function (Wimplinger et al., 2006; 
Wimplinger et al., 2007).  
Beside its primary role in OXPHOS, cytochrome c is a key factor in the apoptotic 
response and deficiency of the mature isoform could lead to a severe impairment in 
the apoptosis process, which in turn is important for a proper neuronal development. 
In fact yeast strains lacking Cyc3p were shown to be more resistant to cell death while 
accumulation in the cytosol of cytochrome c has been shown to inhibit the caspase-
dependent cell death in eukaryote cells (Ludovico et al. 2002; A. G. Martin 2002). 
Thus, as suggested by Wimplinger and coworkers, the functional nullisomy of HCCS 
may alter the balance between apoptosis and necrosis pushing cells toward a caspase-
independent cell death.  
Necrotic cell death is usually accompanied by loss of mitochondrial membrane 
potential, lowering of ATP intracellular concentrations, ROS production and bears the 
danger of inflammatory reactions leading to damage to neighboring cells, which might 
be the reason behind the eye malformations and the other symptoms found in MLS-
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affected patients (Wimplinger et al. 2007). Loss of HCCS function in addition to the 
OXPHOS impairment, typically found in mitochondrial disorders due to dysfunction of 
components and/or assembly factors of the mitochondrial respiratory chain, is  also 
responsible for a severe developmental disorder with eyes and skin defect probably 
imputable to its second function in apoptosome organization (Wimplinger et al. 2006). 
In fact it is well-known that during central nervous system (CNS) and eyes 
embryogenesis development depends on a fine regulation of apoptotic events, that  
represents an important mechanism to regulate the size of cell populations. 
 
4.1.2. Cytochrome c synthesis and import in yeast    
Cytochrome c is a soluble protein localized in the outer surface of the IMM where it 
mediates the electron transfer between complex III and complex IV (Mayer et al. 
1995). Cytochrome c is also involved in the cellular death pathway in vertebrates, by 
signaling mitochondrial status (Bernard et al., 2003; Lim et al., 2002). 
Like most mitochondrial proteins, cytochrome c is encoded in the nucleus, synthesized 
in the cytoplasm and then translocated into mitochondria (Dumont et al. 1988). 
Cytochrome c is synthesized as apocytochrome c without any amino-terminal region 
for correct localization, and its maturation requires the addiction of the heme group, 
covalently attached via thioether linkages to two cysteine residues of the protein 
(Sherman & Stewart 1973; Dumont et al. 1988).  
The covalent attachment of prosthetic group to form the holo-cytochrome c is catalized 
by the enzyme cytochrome c heme lyase (Basile et al. 1980; Dumont et al. 1988). In 
yeast the enzyme is encoded by the nuclear gene CYC3 and then transferred in the 
mitochondrion, where it is found associated with the outer surface of the mitochondrial 
membrane. 
Cytochrome c import requires Tom40 the protease-resistant channel part of the TOM 
complex, Tom 22 and cytochrome c heme lyase acting as a trans-side receptor (Mayer 
et al. 1995; Diekert et al. 2001; Wiedemann et al. 2003).The binding of cytochrome c 
to the enzyme and the folding of the holoprotein are the driving forces responsible for 
the apocytochrome import into intermembrane space (Enosawa & Ohashi 1986; 
Dumont et al. 1991).  
It was proposed that apocytochome c enters into mitochondria crossing the outer 
membrane (OMM) and then interacts with heme lyase; the enzyme, localized in the 
outer face of inner mitochondrial membrane (IMM), might play a role in mitochondrial 
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cytochrome c accumulation acting as a trap and pushing cytochrome c towards 
conformational changes and import into mitochondrial matrix (Dumont et al. 1991).  
It was shown that heme lyase mutants could not accumulate cytochrome c to wild-type 
levels (Dumont et al. 1988; Nargang et al. 1988). 
As previously reported, apocytochrome c can be reversibly imported into mitochondria, 
suggesting that the early steps of translocation do not depend on heme attachment 
(Hakvoort et al. 1990; Dumont et al. 1991). 
   
 
4.1.3.  Effects of HCCS deficiency on mitochondrial functions in yeast 
Due to their role in energy metabolism and in progression through apoptotic pathway 
mitochondria have long been known to be critical for cell survival. As described above 
mutations that affect HCCS negatively impact OXPHOS function and caspase-
dependent apoptosis, leading to a severe and complex syndrome (MLS) that, beside 
the common features of mitochondrial disorders, shows symptoms such as 
neurodevelopmental defects, microphathalmia, sclerocornea and areas of aplastic skin. 
To get a better insight into the contribution of pathogenic HCCS mutations in the 
development of MLS and define HCCS biochemical function and its effect on OXPHOS, 
we analyzed the effect of HCCS deficiency on mitochondrial functions using yeast as a 
model organism.  
For this purpose we performed HCCS complementation studies in the yeast 
Saccharomyces cerevisiae using a strain deficient for the HCCS orthologue, CYC3. In 
particular the B-8025 strain is deleted also in CYC7, which encodes for cytochrome c1 
to eliminate any residual respiratory activity due to the conversion of apocytochrome c1 
in the correspondent holoform by the other heme lyase Cyt2p.   
As previously described, the strain B-8025 deleted in CYC3 is unable to grow on non-
fermentable carbon sources indicating a severely depleted respiratory function 
(Dumont et al., 1987). Transformation of B-8025-cyc3∆ with the human HCCS restored 
mitochondrial respiration and oxidative growth, unlike three forms bearing mutations 
identified in MLS patients. These include two missense mutations (E159K; R217C) 
involving two highly conserved amino acids and a non-sense mutation (D197-268) 
resulting in a HCCS-protein lacking 72 c-terminal amino acids that are required for 
mitochondrial targeting (Wimplinger et al. 2006; Wimplinger et al. 2007). 
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In particular we observed the thermo-sensitive behavior of HCCSE159K mutation. In 
fact when grown at the permissive temperature of 28 °C the mutant HCCSE159K 
showed a remarkable ability to grow on non-fermentable carbon sources, as well as 
wild-type HCCS strain, while did not complement the function at 33 °C. Moreover the 
ability to grow in non-fermentable carbon sources showed by the strain complemented 
with the human wild-type allele appears to be slightly improved when cells are grown 
at 33 °C (Fig.4.4). 
 
 
Figure 4.4. Spot assay at 28 °C and 33 °C in YNB DO-URA and LEU medium supplemented with copper to 
induce expression of the GST-HCCS-fusion proteins. Cells at different concentrations were plated on 
glucose and glycerol containing plates after serial dilutions. 
 
In order to assess the structural integrity of the mitochondrial respiratory chain 
complexes we analyzed the content of mitochondrial cytochromes by measuring their 
absorption spectra. In the B-8025 strain (cyc3Δ) transformed with wild-type HCCS  
human gene the spectra profile was indistinguishable from the strain carrying the CYC3 
wild-type yeast gene (data not shown). On the contrary in the hccs null strain we 
observed a pronounced reduction of the absorption peak corresponding to cytochrome 
c, but also to cytochrome aa3, a component of complex IV. This indicates the loss of 
the structural integrity of complex IV that requires the presence of the folded and 
mature holo-Cytc (Pearce & Sherman 1995).  
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similar behavior was displayed by the cyc3Δ strain transformed with the HCCS mutant 
alleles and pYEX empty vector (Fig.4.5). The disappearance of cytochrome aa3 has 
been reported previously as a secondary effect due to the absence of holo-cytochrome 
c (Barrientos et al., 2003; Bernard et al., 2003). The observed reduction of the 
cytochromes content parallelized with a reduction in the respiratory activity indicating 
that the mutated HCCS alleles identified in MLS patients are pathogenic via impaired 
OXPHOS (Fig.4.5).  
Once again both spectra profiles and respiratory activities show the thermo-sensitive 
behavior of HCCSE159K mutation: the mutant has a mild phenotype at the permissive 
temperature of 28 °C while it is remarkably compromised when grown at 33 °C, at the 
same extent of the cyc3Δ strain.    
 
 
 
Figure 4.5. Cytochrome profiles and oxygen consumption of B-8025 strain transformed with human wild-
type HCCS, the mutants HCCS E159K, HCCS R217C, HCCS ∆197-268, and the empty vector grown in YNB 
DO-URA and LEU supplemented with glucose 0.6% at 28 °C and 33 °C. Cells were grown until glucose 
was exhausted to promote the expression of respiratory chain components. The values are expressed as 
nmol O2*min
-1*(mg dry weight)-1 and standard deviation of four biological replicates normalized to wild-
type is shown. 
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Beside the primary role in the attachment of heme to cytochrome c, heme lyase is also  
responsible for the apo-cytochrome import into intermembrane space. The binding of 
cytochrome c to heme lyase and the folding of the holo-protein are the driving forces 
behind the import, with Hccsp acting as a trans-side receptor (Mayer et al. 1995; 
Diekert et al. 2001; Wiedemann et al. 2003). It has been reported that mitochondria 
from cyc3Δ strains were essentially incapable of importing newly synthesized apo-
cytochrome c and that less than 5% of either CYC1 or CYC7 gene product could be 
found into mitochondria isolated from those strains (Dumont et al. 1988).  
We wondered whether S. cerevisiae strains carrying either wt HCCS or HCCS mutant 
alleles were able to properly import cytochrome c into mitochondria. Western blotting 
were performed on mitochondria with intact outer membrane, using antibody anti 
yeast cytochrome c, to assay the presence/absence of the protein inside mitochondria. 
Of course we did not take into account the truncated form (HCCS D197–268) of the 
heme lyase which was found to be impaired in mitochondrial import. In agreement 
with previous studies, western blotting analysis showed the absence of cytochrome c in 
the cytoplasmic fraction (data not shown) and a great reduction of cytochrome c 
content in mitochondria from the null yeast strain B-8025 (Fig.4.6). We observed that 
mitochondria from strain B-8025 transformed with wild-type HCCS contains levels of 
cytochrome c similar to those present in wild-type strain B-7553 (control parental 
strain, data not shown), while strains transformed with the mutated alleles (HCCS 
E159K, HCCS R217C) show an amount of cytochrome c that is significantly reduced 
compared to that observed in wild-type, but greater than that of null strain. 
 
 
 
Figure 4.6. Western Blot on mitochondria with intact outer mitochondrial membrane of B-8025 strain 
transformed with wild-type HCCS and the mutated alleles HCCS E159K, HCCS R217C or the empty vector, 
grown in YNB DO-URA and LEU media. 40 µg of mitochondria were loaded and Anti-ATP4 antibody is 
used to normalize the loading. 
 
In particular mutant HCCS E159K shows a signal more intense then strain transformed 
with the HCCS R217C allele, despite the absorption spectra profile are similarly 
compromised. This result indicates that whilst both mutant HCCS proteins fail to attach 
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the heme moiety into apo-Cytc, the R217C protein prevents translocation of Cytc, 
whereas the E159K is permissive, suggesting that the import of the heme-less apo-Cytc 
into mitochondria requires the presence of the HCCS protein even if not catalytically 
active. These data point to an additional role of HCCS as an apo-Cytc chaperone; the 
differences between E159K and R217C mutants consist in their ability to physically 
bind, chaperone and drive apo-Cytc to the inner mitochondrial membrane. The 
different accumulation of cytochrome c between HCCS E159K and HCCS R217C 
mutants should be ascribed to a different structural conformation between the two 
heme lyase proteins, possibly modifying their membrane interaction. These results also 
indicate that HCCS directly controls the import of cytochrome c into mitochondria 
independently from its heme lyase activity, suggesting that HCCS binding to apo-
cytochrome c, rather than heme attachment, is the critical step for cytochrome c 
import into mitochondria, as previously proposed (Dumont et al. 1991). 
Respiratory chain dysfunction can lead to an increased production of ROS. When 
electrons transfer along the respiratory chain is inhibited downstream of complex III, 
electrons coming from succinate oxidation can by reverse transported from complex II 
to complex I, leading to ROS generation (Lambert & Brand 2004; St-Pierre et al. 2002). 
ROS production can also increase as a consequence of low respiratory rates, increasing 
the electrons stall along the ETC and the possibility to prematurely escape from 
respiratory chain complexes (Korshunov et al. 1997), or in pathological situations 
associated to mitochondrial respiratory chain defects (Douglas C Wallace 2005). 
In yeast, strains that produce elevated level of ROS display an enhanced sensitivity to 
free radical inducers, because the imposition of an additional exogenous stress 
overwhelms the detoxifying defense mechanisms of the cell. To evaluate the sensitivity 
of hccs∆ mutants to hydrogen peroxide a filter-paper disk method was performed with 
four different concentrations of H2O2. 10e7 cells of each strain were plated on 
YNB+DO- URA and LEU glu 2% as described in the material and methods section. 10 
µl of H2O2 (1%, 2%, 5% and 10%) were adsorbed on sterile Whatman disks (diameter 
9 mm) placed in the middle of the plate. After three days of growth at 33 °C the plates 
were photographed as shown in fig.4.8. The strains analysed were the B-8025 
transformed with wild-type HCCS and the mutated alleles HCCS E159K, HCCS R217C or 
the empty vector.    
Accordingly, H2O2-induced growth inhibition was markedly increased in the B-8025-
cyc3∆ strain defective for heme lyase function as well as  the hccs pathological alleles 
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compared to the wild-type strain, indicating that HCCS deficiency leads to an increase 
of ROS production. 
Since increased ROS production  can affect chronological life span (CLS) we  tested the 
effect of hccs pathological mutations on the survival rates of chronologically aged cells. 
Viability was measured over time by plating serial dilutions of the cultures onto YPD 
plates and counting colony forming units (CFU) after three days of growth. As shown in 
fig.4.7 both the strains carrying the hccs pathological alleles showed a significant 
decrease in  CLS as well as the B-8025-cyc3∆ null mutant, indicating that loss of 
functional HCCS is deleterious for cell survival. 
 
 
 
A) 
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Figure 4.7.  A) Paper disk assay with four different H2O2 concentrations. B) CLS of the B-8025 strain 
transformed with the wt HCCS or the pathological alleles in YNB+DO- URA and LEU supplemented with 
2% glucose. When cells reach the stationary phase their survival is measured. 
 
To gain insight into the role of HCCS in the development of MLS syndrome our 
coworkers decided to investigate a vertebrate animal model.  
HCCS  inactivation results in embryonic steam (ES) cells lethality in mouse preventing 
the possibility to use this model organism to study MLS features. For this reason 
another valuable model was generated, by hccs knock-out in medaka fish. Hccs-
deficient medaka embryos presented the phenotypes observed in MLS patients and 
confirmed the results obtained in yeast: the embryos showed significant reduction of 
complex III activity and Cytc amount, the presence of abnormal mitochondria with 
disorganization of the cristae in morphants retinas, and an increase in ROS content 
which is responsible for caspase-9 activation in the mitochondria. Hccs-deficient 
medaka embryos showed that microphthalmic and microcephalic  phenotype is due to 
the mitochondrial caspase-9 activation that occurs in an apoptosome-independent 
manner, and as a consequence of mitochondrial respiratory dysfunction and ROS 
increase. 
In conclusion we found that in addition to controlling holo-cytochrome c synthesis, 
HCCS has a key role during eye and brain development by controlling the activation of 
a non-canonical pathway leading to cell death in an apoptosome-independent manner, 
via the activation and release of caspase-9 (Indrieri et al. 2012). 
Despite HCCS is ubiquitously expressed and required to maintain cellular respiration 
the phenotypes observed in MLS patients are restricted to specific tissues, suggesting 
that heme lyase dosage and function may be critical in particular organs.  
 
B) 
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MATERIALS AND METHODS 
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5.1. Yeast strains  
 
All S. cerevisiae  yeast strains used in this work are listed below: 
 
STRAIN GENOTYPE ORIGINE 
BY4741 Mata his3-1 leu2-0 met15-0 ura3-0 Euroscarf collection; 
Brachmann et al., 
1998 
 
BY4741 sch9 Mata his3-1 leu2-0 met15-0 ura3-0 
sch9::KANR 
The present work 
BY4741 rei1 Mata his3-1 leu2-0 met15-0 ura3-0 
rei1::KANR 
Collezione Euroscarf; 
Brachmann et al., 
1998 BY4741 tor1 Mata his3-1 leu2-0 met15-0 ura3-0 
tor1::KANR 
BY4741 gpr1 Mata his3-1 leu2-0 met15-0 ura3-0 
gpr1::KANR 
BY4741 tma19 Mata his3-1 leu2-0 met15-0 ura3-0 
tma19::KANR 
BY4741 rpl6 Mata his3-1 leu2-0 met15-0 ura3-0 
rpl6::KANR 
BY4741 rpl31A Mata his3-1 leu2-0 met15-0 ura3-0 
rpl31A::KANR 
BY4741 sdh1 Mata his3-1 leu2-0 met15-0 ura3-0 
sdh1::KANR 
BY4741 sdh2 Mata his3-1 leu2-0 met15-0 ura3-0 
sdh2::KANR 
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BY4741 sdh4 Mata his3-1 leu2-0 met15-0 ura3-0 
sdh4::KANR 
BY4741 sdh5 Mata his3-1 leu2-0 met15-0 ura3-0 
sdh5::KANR 
BY4741 nop6 Mata his3-1 leu2-0 met15-0 ura3-0 
nop6::KANR 
BY4741 rrp8 Mata his3-1 leu2-0 met15-0 ura3-0 
rrp8::KANR 
BY4741 slx9 Mata his3-1 leu2-0 met15-0 ura3-0 
slx9::KANR 
BY4741 arx1 Mata his3-1 leu2-0 met15-0 ura3-0 
arx1::KANR 
BY4741 nsr1 Mata his3-1 leu2-0 met15-0 ura3-0 
nsr1::KANR 
BY4741 puf6 Mata his3-1 leu2-0 met15-0 ura3-0 
puf6::KANR 
BY4741 mrt4 Mata his3-1 leu2-0 met15-0 ura3-0 
mrt4::KANR 
B-7553 MATα can1-100 CYC1 cyc7::CYH2 cyh2 
his3-Δ1 leu2-3,112 trp1-289 
Wimplinger et al., 
2006 
B-8025 MATα can1-100 CYC1 cyc3-Δcyc7-
Δ::CYH2 cyh2 his3-Δ1 leu2-3,112 trp1-
289 
Wimplinger et al., 
2006 
W303 mip1 Mata ade2-1 leu2-3 ura3-1 trp1-1 his3-11 
can1-100 sml1::HIS3/ Matα ade2-1 leu2-
3 ura3-1 trp1-1 his3-11 can1-100 
mip1::KANR  
Baruffini et al., 2006 
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WB-12 MATa ade2-1 trp1-1 ura3-1 can1-100 
aac1::LEU2 aac2::HIS3 
Hashimoto, 1999 
W303-1B bcs1 Matα ade2-1 leu2-3 ura3-1 trp1-1 his3-11 
can1-100 bcs1::KANR  
Tuppen H. et al., 
2010 
 
 
5.2. Media and growth conditions 
For yeast the following media were used:  
 YP (1% peptone, 0.5% yeast extract)  
 YPA (2% peptone, 1% yeast extract, 7.5mg/ml adenine)  
 YNB (YNB ForMedium™ w/o aminoacids w/o NH4SO4 1,9 g/L, NH4SO4 5 g/L). 
Minimum media was enriched with drop-out powder (Kaiser et al. 1994).  
 SD (YNB ForMedium™ w/o aminoacids w/o NH4SO4 6,7 g/L). 
 YPAGE-Ery (2% peptone, 1% yeast extract, 40 mg/L adenine, 25 mM K-
phosphate buffer pH 6.5, 3g/L erythromycin (SIGMA), 3% glycerol, 2% 
ethanol).   
If necessary singles aminoacids could be excluded from complete drop-out to maintain 
selective pressure. As solidifying agent agar ForMedium™ 2% was added. Carbon 
sources were added at final concentration of 2% if not specified differently.  
The following sources were used: Glucose (D), Ethanol (E), Glycerol (G), Galactose 
(Gal), Lactate (L). S. cerevisiae was cultured at 28˚C, in constant shacking 120 rpm if 
liquid media was used. To induce heat stress, cultures were incubated at 37˚C in 
thermostat or water bath.  
 
For E. coli LB media was used (1% bacto tryptone Difco™, 0.5% yeast extract Difco™, 
0.5% NaCl, pH 7.2-7.5). Agar 2% and ampicillin (Sigma-Aldrich®) 100mg/ml were 
added if needed.  
For α-complementation selection 80μl of 5-bromo-4-chloro-3-indolyl-b-D-
galactopyranoside (Xgal) 2% (dissolved in dimethilformamide) and 40μl isopropyl-beta-
D-thiogalactopyranoside (IPTG) 23,8 mg/ml were added. Cultures were incubated at 
37˚C in constant shacking if necessary. 
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5.3. Plasmids 
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5.4. Nucleic Acids manipulation  
All the manipulations were carried out with standard techniques (Maniatis et al. 1982). 
Plasmid DNA was extracted from E. coli with Wizard® Plus SV Minipreps, Wizard® Plus 
Minipreps (©Promega) or following standard procedures (Maniatis et al. 1982). DNA 
recovery from agarose gel and purification of PCR products were carried out with 
Wizard® SV Gel and PCR Clean-up System (©Promega) commercial kit.  
Genomic DNA from S. cerevisiae was extracted as previously described (Hoffman et al. 
1987; Looke et al. 2011).  
Enzymatic manipulations (restriction, ligation, dephosphorylation) were carried out 
following manufacturer indications (New England Biolabs® Inc. NEB, Invitrogen™).  
Sequencing was performed with external services (©Eurofins-MWG for Europe, 
Genewiz® Inc. for United States).  
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5.5. Primers 
 
NAME  OLIGO SEQUENCE 5'-3' 
FwSch9Kan CGTCGAATCAGGATACTGGATTTAGCTCTCAACACCAACATCCCGTACGCTGCAG 
GTCGAC 
RvSch9Kan GGGATAAAGGAACCAGGTTCCATAAAGTACGAGTTTTGTAGGATCGATGAATTCGAGCTCG 
FwSch9Up CGCCGTCGACGATAGACCTCTACAGCTTTTAC 
RvSch9Low GGGCGAATTCCGACTTTGGGAAATCACAGC 
FwRei1Up CGCCGGATCCACTCTCATTCCCGATATTCCC 
RvRei1Low GGCCAAGCTTGCTGTATATTTCCTTTGCTGTA 
K2 GAAAGAAGAACCTCAGTGGC 
SYM-HYGF TCTTTTGTTATTACTATAGGAAAGATAGAATTGATATTAAAACAGCGTACGCTGCAGGTCGA
C 
SYM-HYGR GCTAGTTGAATTCCAAATATTTTCAAAATCAGGATTTCTTATCCAATCGATGAATTCGAGCT
CG 
FwACT1mtDNA GTATGTGTAAAGCCGGTTTTG 
RvACT1mtDNA CATGATACCTTGGTGTCTTGG 
FwCOX1mtDNA CTACAGATACAGCATTTCCAAGA 
RvCOX1mtDNA GTGCCTGAATAGATGATAATGGT 
FwSc5S GGTTGCGGCCATATCTACCAG 
RvSc5S GATTGCAGCACCTGAGTTTCG 
FwSc25S GCCAGCTGGGACTGAGGACT 
RvSc25S GGATTCCCTTTCGATGGTGGCC 
FwACT1_probe GGTTCTGGTATGTGTAAAGCCGGTTTTGC 
RvACT1_probe GAAACACTTGTGGTGAACGATAGATGGACC 
FwABF2_probe GCCTATTAACTAGATCTTTCC 
RvABF2_probe CCTTAATGCTTTGATCCAAGG 
FwACO1_probe GGTATCACAACTGTCAAAGG 
RvACO1_probe CCTCTGTATTTCAACCATGG 
FwILV5_probe CCAGATTGATCTGCAACTCC 
RvILV5_probe GGTACCAGTCCAAAGCACC 
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5.6. Polymerase Chain Reaction  
All the reactions were performed following manufacturer indications. For analytical 
purpose Taq DNA polymerase 2X master mix (NEB) or GoTaq® DNA polymerase 
(©Promega) were used. Preparative reactions (for gene cloning, cassette transfer, 
sequencing) were performed with a high fidelity polymerase. KOD HiFi DNA 
polymerase was used (Novagen®). 
 
5.7. mtDNA copy number analysis by qRT-PCR  
The relative amount of mtDNA and nuclear DNA was determined using a quantitative 
real-time PCR strategy. Separate PCR reactions with SYBR Green and standard PCR 
primers are used to quantify the amplification signals from the mtDNA target and 
nuclear target. 
The yeast strains to be analyzed were grown in 5 ml of liquid YPG medium to an 
optical density (at 600 nm) of 0.6–0.8. The cultures were harvested by centrifugation, 
and total cellular nucleic acids were isolated using a “smash and grab” protocol 
essentially as described previously (Hoffman & Winston 1987). The nucleic acid pellet 
was dissolved in 100 μl of TE buffer containing DNase-free RNase A (10 μg/ml) and 
incubated at 37°C for 1.5 h. This DNA was quantified by absorbance at 260 nm and 
various dilutions (≥80-fold) of the template DNA were used in the final PCR reaction to 
ensure measurements were within the linear range.  
Nuclear DNA and mtDNA PCR were done in individual wells for each sample dilution in 
the following standard 50-μl SYBR Green reaction: 25 μl of Bio-Rad iQ SYBR Green 
Supermix, 10 μl of diluted template, 3 μl of H2O, and 1 μl of each nuclear primer 
(ACT1 forward and reverse primers) or each mtDNA primer (COX3  forward and 
reverse primers).  
Each primer was stored separately as a working stock of 6.25 μM, and the final 
concentration in the above-mentioned reaction for each primer was 125 nM. The PCR 
reaction was performed in 96-well format using a Bio-Rad iCycler and analyzed using 
and accompanying iCycler IQ version 3.1 software. 
Analysis of the data to generate the relative mtDNA copy number of the strains was 
The PCR protocol was empirically designed around a primer annealing temperature of 
58°C, a probe annealing temperature of ∼68°C, and 45 cycles of real-time PCR 
amplification and data collection as described in the iCycler manual.  
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For each strain analyzed, the copy number of the mtDNA and the nuclear DNA is 
calculated using the threshold cycle number (CT), making sure the reactions were in a 
linear range of detection, by running a variety of dilutions. This is done in triplicate to 
obtain an average value for CT for COX1 and ACT1, CT (COX1) and CT (ACT1), 
respectively.  
The difference (ΔCT) between these averages CT (COX1) - CT (ACT1) is determined and 
used to arrive at a value of the relative mtDNA copy number (RCN) of each strain, 
which is equal to 2ΔCT. The fold change in the RCN of each mutant strain is calculated 
by dividing its RCN by the wild-type RCN value, which yields the fold change compared 
with wild type, which now has a value of 1.  
At least three experiments of this type were run for each strain analyzed. 
 
 
5.8. Transformation procedures 
 
5.8.1. E. coli transformation  
E. coli transformation was achieved with electroporation. Competent cells were 
prepared as previously described (Dower et al. 1988). Transformation was carried out 
with 1-3μl of plasmid DNA or ligation product. One mm or 2 mm cuvettes were used, 
applying respectively a current of 1.75KV, 25 µF 200 Ω or 2KV, 25 µF 200 Ω.  
Alternatively, CaCl2 competent cells were prepared and transformed with standard 
techniques (Maniatis et al. 1982).   
 
5.8.2. S. cerevisiae transformation  
Yeast transformation was carried out with Lithium Acetate (LiAc) as described by Gietz 
et al. If a greater efficiency was desired, the long protocol was applied (Gietz et al. 
2002).  
For the one-step gene disruption and episomic plasmids integration (Rothstein 1983) 
the protocol used was modified from Schiestl et al. method (Schiestl et al. 1989) and 
performed as follows:  
1) Inoculate strain to be transformed in 10ml YPD and grow o/n at 30˚C  
2) Inoculate from overnight batch into fresh 10ml YPD to OD600 of about 0.1  
3) Grow cells at 30˚C until OD600 reaches 0.6 to 1  
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4) Harvest 1ml of culture centrifuging 2000-3000rpm for 1-2 minutes. Resuspend 
in 1ml of TEL solution and centrifuge 2000-3000rpm for 5 minutes.  
 
TEL solution: 10mM TrisHCl pH 7.5 
1mM EDTA pH 8 
0.1M LiAc 
 
5) Resuspend pellet in 0.1ml TEL and transfer to a clean sterile eppendorf tube. 
Add transforming DNA (1-10μg) and 5μl of 10mg/ml salmon sperm DNA 
solution (previously denatured for 5 minutes at 95˚C and cooled 2 minutes on 
ice). Mix and incubate 30 minutes at room temperature without shacking  
6) Add 0.7ml of 40% PEG4000 in TEL buffer and mix by pipetting. Incubate 45-60 
minutes at room temperature without shacking  
7) Heat shock at 42˚C for 10 minutes and incubate on ice 2-5 minutes  
8) Pellet for 1 minute and wash once in 0.2ml of TE (10mM TrisHCl pH 7.5, 1mM 
EDTA pH 8). Pellet again for 1 minute ad resuspend in 100μl of sterile water. 
Plate on selective medium.  
 
 
5.9. Whole cell analyses  
 
5.9.1. Spot Assay  
Spot assay is a classical phenotypic analysis used to test growth of single strains in 
different conditions. The principle is a 10-fold serial dilution of a starting culture at 
1*10e7 cells/ml, performed four/five times to a final 1*10e4 cells/ml or 1*10e3 
cells/ml.  
After a o/n culture at 28 °C in YPD or YNBD the OD600 was measured for each strain. 
A first dilution was made to dilute each strain to a concentration of 1 OD (1*10e7). 
Then three or four 10-fold serial dilutions were made. From these suspensions 5μl or 
10μl were spotted in ordered rows on agar plates and then incubated for several days.  
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5.9.2. Filter paper disk-method  
This assay allows to evaluate the strain sensitivity to specific substances. 20 ml of or 
YNBD + DO - Ura + 2% agar were plated and once solidified covered with a 10 ml of 
cells/top agar in order to have a total concentration of 1*10e6 cells.  
These cells were pre inoculated in YNBD +DO - Ura and incubated o/n at 28 °C. After 
measuring OD600, cells were inoculated in 10 ml of Top agar. Once the second lay was 
solidified, a Whatman disk was placed in the plates centre.  
10 μl of the testing substance at desired concentrations were added on the disk and 
after an incubation at 28 °C for 3-4 days, the halos were observed. 
 
5.9.3. Cytochromes spectra absorption  
(Ferrero et al., 1981)  
Mitochondrial respiratory chain intactness can be assessed easily recording the 
cytochromes absorption profile on whole cells. All the experiments were carried out 
with a Cary 300Scan UV-vis spectrophotometer (Varian Inc.), recording continuously 
from 630 to 540nm. The following general protocol was used:  
1. Pre inoculate the strains in 10ml YPD or YNBD+DO- Ura and incubate o/n at 28°C.  
2. Inoculate 2.5ml in 100ml of YPD 0.6% or YNBD+DO-Ura and incubate 24hrs at 
28°C.  
3. After checking that glucose is finished (to be sure that any repression is affecting 
the cells) harvest cells centrifuging 5000rpm 10 minutes, 4˚C.  
4. Resuspend the cells in water proportionally to their humid wet (to normalize 
concentration among different strains).  
5. Register the spectra oxidized versus reduced.  
 
Raw data were processed using Excel functions (Microsoft® Office). WT strain was 
included in each analysis.  
 
5.9.4. Oxygen consumption  
(Ferrero et al., 1981)  
Oxygen consumption was recorded using Oxygraph system from Hansatech, composed 
of a S1 Clark electrode core controlled with Oxygraph Plus software (Hansatech 
Instruments Ltd.). 
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 Cells were obtained as described for cytochromes spectra recording. 100μl were 
added to 900μl of K-ftalate 0.1M pH5 in the chamber. Oxygen decrease was recorded 
for at least 1 minute. 100μl of cell suspension were exsiccated at 37˚C for 48hrs and 
dry wet estimated.  
Oxygen consumption rate was expressed as nmol O2 for minute for mg of cells 
(nmol/min mg).  
 
5.9.5. In Vivo Labeling of Mitochondrial Products with 35S-met  
1. Strains were grown on YPD plates and inoculate at very low concentration in 10ml of 
synthetic minimum media with galactose and auxotrophic requirements. This step can 
also be performed in YPD media. Grow until OD600 is 0.6 – 2 maximum.  
2. Harvest equivalent of 0.6 OD in eppendorf tube. Centrifuge 1 minute 6000-8000rpm.  
3. Wash the pellet with 500μl of 40mM phosphate pH 6, galactose 2% (Important: 
repeat twice this step if cells were grown in complete media to eliminate any residual 
methionine). Resuspend cells in 500μl of the same buffer.  
4. Add 10μl of freshly prepared cycloheximide (10mg/ml in water), mix and incubate 
2.5 minutes at 30˚C (or the temperature at which the cells were grown).  
5. Add 2.5-4μl of 35S-methionine (10Ci/ml). Mix and incubate for a definite time 
depending on the experiment (usually 5 to 15 minutes). 
6. Chase of mitochondrial translation products was performed by stopping the reaction 
with the addiction of 40 mM of puromycin and 25 Mm cold methionine. After different 
time periods (from 30 to 120 minutes) aliquots were removed and protein extracted. 
7. Centrifuge 1 minute at maximum speed and resuspend cells in 75μl of Rodel Mix 
(protect stock solution from light). Immediately add 500μl of bidistilled H2O. Add 575μl 
of 50% tri-chloroacetic acid (TCA). Incubate at least 15 minutes on ice. Centrifuge 
15000rpm, 10 minutes.  
 
Rodel Mix: 5.56ml 5M NaOH 
1.11ml ß-mercaptoethanol 
6.84ml H2O 
1.5ml 0.1M PMSF 
 
8. Wash pellet once without resuspending with 0.5M Tris-Base (no pH adjusted) to 
neutralize TCA. Wash once without resuspending with bi-distilled H2O.  
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9. Resuspend in 25μl of 1X Loading Buffer without heating. Load on 17.5% SDS-PAGE 
(10X15cm separating gel at least).  
 
Loading Buffer 1X: 2% SDS 
10% Glycerol 
60mM Tris-HCl, pH 6.8 
2.5% ß-mercaptoethanol 
bromophenol blue 
 
10. Run until blue reaches the bottom, without exiting the gel. Maximum 40mA.  
11. Semidry transfer to nitrocellulose membrane for 1hr 30minutes at 200mA. Let the 
membrane dry for few minutes at 37˚C and perform a first exposition of about 24 hrs.  
Buffers and gel composition 
 
Solution Separating Gel 17.5% Stacking Gel 5% 
 
30% acrylamide 0.2 bis-acrylamide  12.61ml  1.079ml  
1.825M TrisHCl pH 8.8  4.55ml  -  
0.6M TrisHCl pH 6.8  -  0.650ml  
water  4.55ml  4.620ml  
SDS 10%  217μl  65μl  
APS 10%  109μl  32.5μl  
TEMED  7.8μl  6.5μl  
final volume  22.1ml  6.5ml  
  
Running Buffer: 50mM Tris-HCl, pH 8.3 
384mM glycine 
0.1% SDS 
 
Prepare a 5X stock solution (30gr Tris-Base, 144gr glycine, 5gr SDS for 1 liter). Dilute 
to 1X and adjust the pH precisely to pH 8.3. The pH is crucial for optimal proteins 
resolution. Check frequently the pH of 1X running buffer. 
 
5.9.6. Crude Total Protein Extraction  
1. Grow cells overnight to 0.7-1.2 OD  
2. Harvest the equivalent of 1.2OD of cells by centrifugation 1min 6000-8000rpm  
3. Wash once with water and resuspend the pellet in 75μl of Rodel mix (see above)  
4. Add 500μl of water  
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5. Add 575μl of TCA50%  
6. Incubate on ice at least 15 minutes. Centrifuge 15000rpm 10min  
7. Wash pellet once with 0.5M Tris-base without resuspending (about 1ml)  
8. Wash pellet once with water without resuspending (about 1ml)  
9. Resuspend in 25μl of 1X LB and add few μl of Tris-base if the color is yellowish  
 
5.9.7. Chronological lifespan assay 
Yeast strains were pre-inoculated in 10 ml of YPD or SD O.N and after were inoculated 
to an OD600 of 0.05 in 100 ml total volume in 25o ml flasks and incubated at 28° C in 
an orbital shaker moving at 200 rpm.  
Viability was assayed either by staining a 100 ml sample of the culture with 100 ml of 
trypan blue (0.4 mg/ml), incubating at 28° C for 5 min, and counting clear versus blue 
cells or by plating serial dilutions onto YPD plates, as indicated. 
 
5.9.8. Treatment with ethidium bromide 
1. Cells were pre-grown in YPD medium. 
2. Cells were inoculated at 1*106 cells/ml in 2 ml of YPD supplemented with 
ethidium bromide 30 µg/ml and incubated at 28° C for one day. 
3. Repeat point two twice. 
4. 300 colonies were plated on YPD and after 24-48 hours some of the grown 
colonies are streaked on YPD and YPE plates. 
5. After 3 days ρ0 cells will be grown on YPD plates but not on YPE.  
 
5.9.9. Aconitase activity assay 
1. Harvest 50 ml of cells at OD between 0.5 and 1. All samples must have the   
same OD, because aconitase activity is susceptible to OD changes. 
2. Pellet and get rid of the supernatant. 
3. Resuspend pellet in 30 ml of ice cold lysis buffer, pellet and get rid of the 
supernatant. 
4. Resuspend pellet in 1 ml of ice cold lysis buffer. 
5. Transfer cells to ice-cold eppendorf tubes. 
6. Spin at max speed for 5 minutes in cold room. 
7. Get rid of supernatant and resuspend pellet in 200 µl of ice-cold lysis buffer. 
8. Store at -80 °C for 1 hour or even days. 
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9. Thaw cells on ice. Resuspend cells. 
10. Add cold glass beads to cells, vortex cells for 30’’ and put them on ice. Repeat 
this step 7 times. 
11. Spin at maximum speed in cold room for 5 minutes. 
12. Transfer the top layer to a new tube and perform the assay within 1 hour.  
 
Cell lysis buffer: 
50 mM Tris pH 8.0, 50 mM KCl, 2 mM sodium citrate, 10% glycerol. 
Reaction mixture (for 25 reactions): 
1 M Tris HCl pH 8.0, 10 mM MgCl2, 10 mM NADPH+, 8 units of ICDH. 
 
Aconitase assay is carried out by mixing 240 µl of reaction mix, 16 µl of citrate and 48 
µl of cell extract in a final volume of 800 µl.  A Cary 300Scan UV-vis spectrophotometer 
(Varian Inc.)is used to perfor the assay, recording continuously at 340 nm. 
 
5.10. Mutational rate analysis 
 
5.10.1. mtDNA stability analysis  
mtDNA stability was evaluated by the frequency of spontaneous cytoplasmic petite. 
They grow as small colonies on medium supplemented with respiratory carbon sources 
such as ethanol and glycerol. The protocol is the following:  
1. The pre-existing petite are counter-selected on YPE 2% medium.  
2. Replicate the YPE 2% plates on selectable medium supplemented with 2% glucose. 
The strains are grown for 24h at 28°C.  
3. Replicate on a new plate of the same medium and incubate again for 24h.  
4. Resuspend a part of cells in H2O and evaluate the cellular concentration.  
5. Plate 250 cells on YPD or YNB medium supplemented with 0.6% glucose and 2% 
ethanol. Incubate at 28°C for 5-6 days and count the cells.  
 
0.6% glucose is added in order to allow the growth of petite mutants which are 
respiratory deficient and are unable to use ethanol like the “wt” cells. When glucose is 
exhausted the wild-type cells uses ethanol to grow, while the petite mutants arrest 
their growth. Indeed the petite mutants will form small colonies unlike the big colonies 
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formed by wt cells. For further controls, the single colonies can be patched on a 
medium containing a respiratory carbon source. 
 
5.10.2. Determination of EryR mutant frequency 
A clone from each mutant and wt strains is streaked on SCD or YPD plates. After 1 day 
at 28° C, cells are picked up with a toothpick, suspended in water, counted, diluted 
and plated on SCD or YPD to a final concentration of 100 cells/plate.  
After 2 days at 28° C, nine colonies from each clone are picked up and suspended 
separately in 2 ml of SCE or YPGLY. After 2 days at 28° C under vigorous shaking, 1.5 
ml of each culture is transferred into an Eppendorf tube. The cell pellet is collected by 
centrifugation at 5000g for 15 s, suspended in 200 µl of water and spread in a YPAEG-
Ery plate.  
To determine the number of cells spread on YPAEG-Ery plates aliquots of the cell 
cultures are diluted to 1:500,000, plated on YPGLY plates and counted after 3 days of 
growth. After 8 days of incubation, the EryR colonies grown on YPAEG-Ery plates are 
counted. For each of the nine clones, the ratio of the number of EryR colonies to the 
total number of plated cells is calculated. The EryR mutant frequency is defined as the 
median of the nine ratios. For each strain the experiment is performed at least three 
times, and the EryR mutant frequency is calculated as the mean value of the three 
median values. 
 
5.10.3. Nuclear DNA point mutability 
Canavanine is a toxic equivalent of the arginine, transferred in to the cytosol by the 
same carrier used by the aminoacid. Point mutations on the gene that encodes for the 
carrier lead to the generation of strains resistant to canavanine (CANR). the number of 
CANR strains that spontaneously arise in a population is used as an indicator of nuclear 
genome mutability rate. The measure of the CANR mutant frequency was performed as 
indicated below: 
1. Cells are pre-grown in YP or YNB supplemented with 2% glucose. 
2. For each strain 2*105 cells/ml are inoculated in nine tubes containing YPD or 
YNB+D and incubated at 28° C under vigorous shaking until they reach the 
final concentration of 1*108. 
3. Cells are collected by centrifugation at 5000 rpm for 5’, resuspended in 1 ml of 
sterile water and washed. 
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4. Cells are finally resuspended in 100 µl of sterile water and plated on YNB+ Glu 
2%+ the aminoacids required and canavanine (6 mg/100 ml). 
5. Plates are incubated at 28° C for 6 days and the number of resistant colonies is 
counted. 
 
5.11. Mitochondrial analysis 
  
5.11.1. Preparation of yeast mitochondria with intact outer membrane  
(Glick et al., 1995)  
1. Harvest cells at 2000-3500 rpm for 7 minutes and wash once with sorbitol 1.2M.  
2. Resuspend washed cells in digestion buffer at concentration of 1gr of cells in 3ml  
 
Digestion Buffer: 30ml 2M sorbitol 
3ml 1M phosphate buffer, pH 7.5 
0.1ml 0.5M EDTA pH 8 
0.5ml ß-mercaptoethanol 
50mg of zymolyase 20000 
16ml of water (Vf=50ml) 
 
Incubate at 30˚C or 37˚C depending on the used growth conditions until most of the 
cells have been converted to spheroplasts.  
3. Add cold Buffer A and immediately centrifuge 4000rpm for 10 minutes. Wash two 
additional times with Buffer A  
 
Buffer A: 1.2M deionized sorbitol (BioRad® AG501-X8 resin) 
20mM KPO4 pH 7.5 
 
4. Suspend washed spheroplasts in 0.6M sorbitol, 20mM KMES pH 6, 0.5mM PMSF at 
concentration of 1gr/3ml. Homogenize with and glass/Teflon pestle and overhead 
stirrer (Wheaton Science Products).  
5. Centrifuge 3000rpm for 5 minutes to pellet debries. Collect the supernatant and 
centrifuge 12000rpm for 10 minutes to sediment mitochondria. The supernatant is the 
post mitochondrial fraction (PMS) and represent the cytosolic component.  
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6. Suspend mitochondria briefly with plastic sticks in 0.6M sorbitol, 20mM KMES pH 6 
(1ml/g of starting cells wet weight) in eppendorf tubes. Centrifuge at 3000rpm for 5 
minutes to pellet broken mitochondria.  
7. Collect supernatant and centrifuge at 12000rpm for 10 minutes. Suspend 
mitochondrial pellet in 0.6M sorbitol, 20mM KMES (100 μl/g of starting cells wet 
weight) and dilute with 20ml of 0.6M sorbitol, 20mM HEPES pH 7.4 (1ml/g of starting 
cells wet weight). Centrifuge 12000rpm for 10 minutes.  
8. Suspend mitochondrial pellet in 0.6M sorbitol, 20mM HEPES accordingly to the pellet 
dimension. Mitochondria can be stored at -80˚C.  
 
5.11.2. Quantification of proteins with Bradford method  
Protein concentration was determined with Bradford method (Bradford, 1976). The 
“BioRad Protein Assay” commercial kit was utilized according to the manufacturer’s 
instructions.  
 
5.11.3. Succinate Dehydrogenase (SQDR) enzymatic activity  
This assay measures the rate of reduction of an artificial electron acceptor as 
dichlorophenolindophenol (DCPIP) by complex II as modified by Kim and Beattie, 1973.  
Solutions needed:        
 100 mM K-phosphate pH 7.8 (30°C) 
10 mM succinate pH 7.4 
2.5 mM phenazyne methosulfate (PMS) 
0,15 mM DCPIP 
100 mM NaN3 
 
The SDH activity was recorded at 600nm.  
Specific Activity: SQDR activity was calculated with ε of 21 and the following formula 
(ΔOD*ε/min mg). 
 
5.12. Protein separation with SDS-page  
Protein separation with SDS-page was performed with classical Laemmli system 
(Laemmli 1970). Separating gels were prepared at 12% polyacrylamide (30:0.8 
acrylamide-bis), stacking gel at 6%. Running was performed for 1hr 30’ at 100-
120volts.  
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5.13. Western Blotting and Ig-detection  
Separated proteins were transferred to nitrocellulose membrane by electroblot for 1hr 
15’ at 200mA. Semi-dry blotting system was used. Quality of the blot was assessed 
with Ponceau S staining.  
Transfer Buffer: 200mM glycine 
25 mM Tris 
20% methanol 
 
Membranes were blocked 1hr with 5% non-fat dry milk prepared in washing buffer and 
incubated o/n with appropriate primary antibody (mono or polyclonal).  
 
 
Washing Buffer: TBS 1% 
tween 0.1% 
 
Blocked membranes were washed 4 times 15 min with washing buffer prior incubation 
with suitable secondary antibodies (Anti-Rabbit, Anti-Mouse), conjugated with 
horseradish peroxidase (1:5000 in 5% milk if anti rabbit Ig, 1.5% milk if anti mouse). 
After 1hr incubation membranes were washed as above and developed with ECL based 
immune revelation. If greater sensitivity was necessary SuperSignal West Femto or 
Pico commercial kits were implemented (© Thermo Scientific). 
Primary antibodies used: 
 Anti-Cox2p (1:1000) (G. Shadel laboratory) 
 Anti-Cox3p (1:1000) (G. Shadel laboratory) 
 Anti-Cox4p (1:1000) (G. Shadel laboratory) 
 Anti-Sod2p (1:1000) (G. Shadel laboratory) 
 Anti-actin (1:1000) (G. Shadel laboratory) 
 Anti-porin (1:1000) (G. Shadel laboratory) 
 Anti-8-oxodeoxyguanine (1:1000) (G. Shadel laboratory) 
 Anti-cytochrome c (1:1000) (a kind gift from A. Barrientos) 
 Anti-Atp4 (1:1000) (a kind gift from Prof. J. Velours)  
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All the antibodies listed below were incubated with Anti-Mouse secondary antibodies 
with the only exception of anti-Sod2p (anti-rabbit ) and anti-8-oxodeoxyguanine (anti- 
goat). 
 
5.14. Dot Blot assay on nuclear and mtDNA 
Total cellular DNA, from cells grown in YPD until OD600 1, was extracted by “smash 
and grab” protocol (previously described). DNA was resuspend in 100 µl of TE+RNase, 
incubate 1 hour 65° C and then incubated with 20 µl of proteinase K for an additional 
hour at 65° C.  
DNA was extracted again with phenol:chloroform, and resuspended in TE. DNA was 
quantified using the nanodrop and aliquots of 5 and 10 µg diluted in 250 µl of TE are 
prepared per each sample.  
The nylon membrane was cut and pre-soak in TE, dot blotter was assembled, samples 
were placed in wells, and vacuum was turned on to adhere samples to the membrane. 
Wells were washed with 250 µl TE in case any DNA remains stuck to the sides of the 
wells. When all liquid has passed through the membrane, disassemble the dot blotter. 
Membrane is dried for at least 1 hour at 55° C or overnight at 37° C. From this point 
on, the dot blot was treated as a normal western blot. 
 
5.15. Total RNA extraction from yeast and Northern Blot analysis 
Yeast cells were grown O.N in the appropriate medium until they reach an OD600 
between 0.8-1.2 and total RNA was prepared by phenol extraction as previously 
described (Ausubel et al. 1994). 
30 µg of RNA for each sample are separated on agarose gel containing formaldehyde 
(as denaturing agent to limit the formation of secondary RNA structures), running at 
least 3 hours at 100 V. 
RNA is then transferred to a nylon membrane Hybond-N+ (Amersham) by capillarity 
(Sherman et al. 1986). Labeling of the oligonucleotide probes is performed by using 
the “Rediprime II DNA labeling System” kit (GE Healthcare) plus 5 µl of 32P dCTP.  
Hybridization is carried out O.N and thereafter the filter is washed many times and 
revealed using Kodak films. As control a probe direct against the ACT1 mRNA is 
used.The signals obtained are then quantified using Phosphorimager (Molecular 
Dynamics). 
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5.16. Flow cytometry 
Cell from a growing culture, once reached OD600, were pelleted by centrifugation and 
washed with phosphate-buffered saline (PBS). For ROS amount measure cells were 
resuspended with 500 µl of PBS supplemented with DHE 5mM and incubated at 28° C 
for 15 minutes.  
For measurement of mitochondrial potential, cells from a growing culture were pelleted 
DiOC6 (Molecular Probes) was diluted to a final concentration of 200 nM in PBS and 
used to resuspend the cells. The cell suspension was then incubated for 30 minutes at 
28 ° C.  
Once incubation was finished cells were washed twice with PBS, and analyzed by flow 
cytometry using the FL1 (for DHE staining) or FL3 (for DiOC6) channel without 
compensation. All analysis was performed on a Beckton-Dickenson FACSCalibur. 
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